Apparatus for measuring pulse-wave propagation velocity

Information

  • Patent Grant
  • 6368282
  • Patent Number
    6,368,282
  • Date Filed
    Thursday, December 30, 1999
    25 years ago
  • Date Issued
    Tuesday, April 9, 2002
    22 years ago
Abstract
An apparatus for measuring a propagation velocity of a pulse wave which is propagated through an artery of a living subject, the apparatus including an electrocardiographic-waveform detecting device which detects an electrocardiographic waveform from the subject, a pulse-wave sensor which is adapted to be worn on the subject and which detects the pulse wave from the subject, a time-difference determining device for determining a time difference between a first periodic point relating to the detected electrocardiographic waveform and a second periodic point relating to the detected pulse wave, and a propagation-velocity determining means for determining the propagation velocity of the pulse wave based on the determined time difference.
Description




BACKGROUND OF THE INVENTION




1. Field of the Invention




The present invention relates to an apparatus for measuring the velocity of propagation of a pulse wave which is propagated through an artery of a living subject.




2. Related Art Statement




The blood pressure, degree of arterial sclerosis, peripheral resistance, etc. of a living subject can be estimated based on the velocity of propagation of a pulse wave which is propagated through an artery of the subject. There is known a pulse-wave propagation velocity measuring apparatus including a pair of pulse-wave sensors which are put on different locations on the skin of a living subject to press different portions of an artery of the subject via the skin and detect respective pulse waves from the artery. The measuring apparatus determines a pulse-wave propagation velocity based on the phase difference of the two pulse waves detected through the two sensors. The measuring apparatus is disclosed in, e.g., Unexamined Japanese Patent Application laid open for inspection purposes under Publication No. 60(1985)-220037.




The prior measuring apparatus measures the pulse-wave propagation velocity through the pulse-wave sensors being pressed against two portions of a superficial artery, such as carotid artery, radial artery, or dorsal pedal artery, that is adjacent to the skin of the subject. In this case, however, the time difference between the time of occurrence or detection of a heartbeat-synchronous pulse of one of the two pulses waves and the time of occurrence or detection of a corresponding heartbeat-synchronous pulse of the other pulse wave is small, because the length or distance between the two portions of the superficial artery is short. Thus, the time difference may not be relied upon for providing a very accurate pulse-wave propagation velocity.




SUMMARY OF THE INVENTION




It is therefore an object of the present invention to provide an apparatus for measuring a very accurate pulse-wave propagation velocity.




The above object has been achieved by the present invention. According to a first aspect of the present invention, there is provided an apparatus for measuring a propagation velocity of a pulse wave which is propagated through an artery of a living subject, the apparatus comprising an electrocardiographic-waveform detecting device which detects an electrocardiographic waveform from the subject, a pulse-wave sensor which is adapted to be worn on the subject and which detects the pulse wave from the subject, time-difference determining means for determining a time difference between a first periodic point relating to the detected electrocardiographic waveform and a second periodic point relating to the detected pulse wave, and propagation-velocity determining means for determining the propagation velocity of the pulse wave based on the determined time difference.




In the pulse-wave measuring apparatus in accordance with the first aspect of the invention, the time difference determined by the time-difference determining means contains a time duration when the pulse wave is propagated through the aorta directly connected to the heart of the subject. Therefore, the length of the artery through which the pulse wave is propagated is increased and accordingly the time difference is increased. In addition, since the diameter of the aorta is large and accordingly the velocity of the pulse wave being propagated through the aorta is decreased, the time difference is increased. Thus, the present apparatus provides a very accurate pulse-wave propagation velocity. Therefore, the degree of arterial sclerosis, or the blood pressure, of the subject can be estimated with high accuracy based on the thus determined pulse-wave propagation velocity.




According to a preferred feature of the first aspect of the invention, the pulse-wave sensor comprises a pressure sensor which is adapted to be pressed against a portion of the artery of the subject via a skin of the subject and which detects, as the pulse wave, a heartbeat-synchronous pressure oscillation which is transmitted thereto from the portion of the artery via the skin. In the case where the present invention is applied to a BP monitor apparatus including an identical pressure sensor for monitoring BP values of a subject, the pressure sensor is used for the two purposes, one for detecting a pulse wave and thereby measuring a pulse-wave propagation velocity and the other for monitoring BP values. The BP monitor apparatus having the pulse-wave propagation velocity measuring function enjoys a reduced production cost.




According to another feature of the first aspect of the invention, the pulse-wave sensor comprises an inflatable cuff which is adapted to be wound around a body portion of the subject, and a pressure sensor which detects, as the pulse wave, a heartbeat-synchronous pressure oscillation which is produced in the cuff. In the case where the present invention is applied to a BP measuring apparatus including identical cuff and pressure sensor for measuring a BP value of a subject, the cuff and pressure sensor are used for the two purposes, one for detecting a pulse wave and thereby measuring a pulse-wave propagation velocity and the other for measuring a BP value. The BP measuring apparatus having the pulse-wave propagation velocity measuring function enjoys a reduced production cost.




According to another feature of the first aspect of the invention, the pulse-wave sensor comprises a photoelectric sensor including a light source which emits a light toward a body portion of the subject, and a light detecting element which detects the light transmitted through, or reflected from, the body portion. In the case where the present invention is applied to a blood-oxygen-saturation measuring apparatus (e.g., so-called pulse oximeter) having an identical photoelectric sensor for measuring a blood oxygen saturation of a subject, the photoelectric sensor is used for the two purposes, one for detecting a pulse wave and thereby measuring a pulse-wave propagation velocity and the other for measuring a blood oxygen saturation. The oxygen-saturation measuring apparatus having the pulse-wave propagation velocity measuring function enjoys a reduced production cost.




According to a second aspect of the present invention, there is provided an apparatus for measuring a propagation velocity of a pulse wave which is propagated through an artery of a living subject, the apparatus comprising a blood-pressure measuring device which measures a blood pressure value of the subject, an electrocardiographic-waveform detecting device which includes a plurality of electrodes adapted to contact a body surface of the subject and which detects an electrocardiographic waveform from the subject through the electrodes, a pulse-wave sensor which is adapted to be worn on the subject and which detects the pulse wave from the subject, time-difference determining means for determining a time difference between a first periodic point relating to the detected electrocardiographic waveform and a second periodic point relating to the detected pulse wave, propagation-velocity determining means for determining the propagation velocity of the pulse wave based on the determined time difference, and propagation-velocity modifying means for modifying the determined propagation-velocity value to a modified propagation-velocity value corresponding to a predetermined blood pressure value, based on the measured blood pressure value, according to a predetermined relationship between modified propagation velocity, and determined propagation velocity and measured blood pressure.




While the pulse-wave propagation velocity is influenced by the degree of arterial sclerosis, it is also influenced by the blood pressure and/or the pulse rate of the subject. However, the blood pressure (BP) values of the subject will change more or less in different measurements. Therefore, the propagation velocity measured by the prior apparatus may not directly be used as an index indicative of a degree of arterial sclerosis. In the pulse-wave propagation velocity measuring apparatus in accordance with the second aspect of the invention, however, the modified pulse-wave propagation velocity provided by the propagation-velocity modifying means can directly be used as an index indicative of a degree of arterial sclerosis. Thus, even if the BP or pulse-rate values obtained from the subject in different measurements may differ from each other, the present apparatus modifies each measured propagation velocity value to a modified propagation velocity corresponding to the predetermined BP value. Accordingly, a series of modified propagation-velocity values can directly be used as an index indicative of a time-wise change of the degree of arterial sclerosis of the subject.




According to a preferred feature of the second aspect of the invention, the propagation velocity measuring apparatus further comprises a pulse-rate measuring device which measures a pulse rate value of the subject, and the propagation-velocity modifying means comprises means for modifying the determined propagation-velocity value to the modified propagation-velocity value corresponding to the predetermined blood pressure value and a predetermined pulse rate value, based on the measured blood pressure value and the measured pulse rate value, according to the predetermined relationship between modified propagation velocity, and determined propagation velocity, measured blood pressure value, and measured pulse rate. Since the thus modified propagation-velocity value corresponds to both the predetermined BP and pulse-rate values, it is more accurate than a modified value corresponding to only the predetermined BP value, because the former value is free from influences from the fluctuation of the pulse rate whereas the latter value is subject to them.




According to another feature of the second aspect of the invention, the propagation velocity measuring apparatus further comprises coefficient determining means for determining a coefficient which is variable with the propagation velocity determined by the propagation-velocity determining means and with the blood pressure measured by the blood-pressure measuring device, and the propagation-velocity modifying means comprises means for modifying the determined propagation-velocity value to the modified propagation-velocity value corresponding to the predetermined blood pressure value, such that the modified propagation-velocity value is equal to a product of the determined coefficient and a difference between the predetermined blood pressure value and the measured blood pressure value. Thus, the modified propagation velocity is determined using the coefficient which is determined based on the propagation velocity and the diastolic BP value each obtained from the subject. Owing to the coefficient, the modified value is free from influences or fluctuations due to the differences of individual persons regarding the degree of arterial sclerosis. Therefore, the modified propagation-velocity values obtained from different subjects can be compared with each other for comparing the respective degrees of arterial sclerosis of those subjects.




According to another feature of the second aspect of the invention, the propagation velocity measuring apparatus further comprises means for determining a degree of arterial sclerosis based on the modified propagation-velocity value according to a predetermined relationship between degree of arterial sclerosis and modified propagation velocity.




According to a third aspect of the present invention, there is provided an apparatus for measuring a propagation velocity of a pulse wave which is propagated through an artery of a living subject, the apparatus comprising a blood-pressure measuring device which includes an inflatable cuff adapted to be wound around a body portion of the subject, a pulse-wave sensor which detects the pulse wave transmitted from the artery of the subject to the cuff when a pressure in the cuff is changed, and means for determining a blood pressure value of the subject based on the detected pulse wave, an electrocardiographic-waveform detecting device which includes a plurality of electrodes adapted to contact a body surface of the subject and which detects an electrocardiographic waveform from the subject through the electrodes, time-difference determining means for successively determining a time difference between a first periodic point relating to the detected electrocardiographic waveform and a second periodic point relating to the detected pulse wave, temporary-propagation-velocity determining means for successively determining a temporary propagation velocity of the pulse wave based on each of the successively determined time-difference values, judging means for judging whether the change of each of the successively determined temporary propagation-velocity values with respect to the change of the cuff pressure is smaller than a reference value, and proper-propagation-velocity determining means for determining a proper propagation velocity from at least one temporary propagation-velocity value for which a positive judgment is made by the judging means.




There is known a BP measuring device which includes an inflatable cuff adapted to be wound around a body portion of the subject, a pulse-wave sensor which detects the pulse wave transmitted from the artery of the subject to the cuff when a pressure in the cuff is changed, and means for determining a blood pressure value of the subject based on the detected pulse wave. The BP measuring device is disclosed in, e.g., U.S. patent application Ser. No. 08/273,929. In the case where the present invention is embodied with the BP measuring device, however, the (temporary) propagation-velocity values determined by the (temporary) propagation-velocity determining means gradually increase as the pressure of the cuff gradually decreases, when the cuff pressure is changed in a range above a mean BP value of the subject. In the pulse-wave propagation velocity measuring apparatus in accordance with the third aspect of the invention, the judging means judges whether the change of each of the determined temporary propagation-velocity values with respect to the change of the cuff pressure is smaller than a reference value, and the proper-propagation-velocity determining means determines a proper propagation velocity from at least one temporary propagation-velocity value for which a positive judgment is made by the judging means. Since the proper propagation-velocity value is determined from the temporary propagation value or values that is or are stable independent of the change of cuff pressure, the accuracy of measurement of pulse-wave propagation velocity is improved.




According to a preferred feature of the third aspect of the invention, the proper-propagation-velocity determining means comprises means for determining, as the proper propagation velocity, an average of a plurality of temporary propagation-velocity values for each of which the positive judgment is made by the judging means. The thus determined proper propagation velocity enjoys a higher accuracy than a proper propagation velocity as one of a plurality of temporary propagation-velocity values for each of which the positive judgment is made by the judging means. However, the proper-propagation-velocity determining means may comprise means for determining, as the proper propagation velocity, a temporary propagation-velocity values for which a positive judgment is made by the judging means.




According to another feature of the third aspect of the invention, the propagation velocity measuring apparatus further comprises proper-propagation-velocity modifying means for modifying the determined proper propagation-velocity value to a modified proper propagation-velocity value corresponding to a predetermined blood pressure value, based on the measured blood pressure value, according to a predetermined relationship between modified proper propagation velocity, and determined proper propagation velocity and measured blood pressure.




According to another feature of the third aspect of the invention, the propagation velocity measuring apparatus further comprises means for determining a degree of arterial sclerosis of the subject based on the modified proper propagation-velocity value according to a predetermined relationship between degree of arterial sclerosis and modified proper propagation velocity.




According to a fourth aspect of the present invention, there is provided an apparatus for measuring a propagation velocity of a pulse wave which is propagated through an artery of a living subject, the apparatus comprising a blood-pressure measuring device which includes an inflatable cuff adapted to be wound around a body portion of the subject, a pulse-wave sensor which detects a plurality of heartbeat-synchronous pulses of the pulse wave transmitted from the artery of the subject to the cuff when a pressure in the cuff is changed, and means for determining a blood pressure value of the subject based on variation of respective amplitudes of the detected heartbeat-synchronous pulses of the pulse wave, an electrocardiographic-waveform detecting device which includes a plurality of electrodes adapted to contact a body surface of the subject and which detects an electrocardiographic waveform from the subject through the electrodes, time-difference determining means for successively determining a time difference between a first periodic point relating to each of heartbeat-synchronous pulses of the detected electrocardiographic waveform and a second periodic point relating to a corresponding one of the detected heartbeat-synchronous pulses of pulse wave, propagation-velocity determining means for successively determining a propagation velocity of the pulse wave based on each of the successively determined time-difference values, judging means for judging whether the change of each of the successively determined propagation-velocity values with respect to the change of the cuff pressure is smaller than a reference value, and correcting means for correcting at least one first pulse of the heartbeat-synchronous pulses of the pulse wave which is deviated from at least one second pulse for which a positive judgment is made by the judging means, based on the deviation of the first pulse from the second pulse, so that the blood-pressure measuring device measures the blood pressure value of the subject based on the variation of the respective amplitudes of the heartbeat-synchronous pulses including the corrected first pulse.




In the case where the present invention is embodied with the BP measuring device which determines a BP value of the subject based on variation of respective amplitudes of heartbeat-synchronous pulses of the pulse wave obtained when the cuff pressure is changed, the relationship of correspondence of pulse amplitude and cuff pressure (or blood pressure) may break for a certain reason during each BP measuring operation of the BP measuring device. Hence, if a first pulse of the heartbeat-synchronous pulses of the pulse wave is deviated from one or more second pulses corresponding to one or more propagation-velocity values for each of which a positive judgment is made by the judging means, the correcting means corrects the first pulse, e.g., amplitude of the first pulse, or value of the cuff pressure at the time of detection of the first pulse, so that the BP measuring device measures a BP value of the subject based on the variation of respective amplitudes of heartbeat-synchronous pulses including the corrected first pulse. Thus, the accuracy of measurement of BP values is improved.




According to a preferred feature of the fourth aspect of the invention, the correcting means comprises estimating means for estimating, based on a plurality of the determined propagation-velocity values for each of which the positive judgment is made by the judging means, a next propagation-velocity value which will be determined by the propagation-velocity determining means, and difference determining means for determining a difference between the estimated next propagation-velocity value and an actual next propagation-velocity actually determined by the propagation-velocity determining means.




According to another feature of the fourth aspect of the invention, the correcting means further comprises means for determining a correction value based on the determined difference according to a predetermined expression, and adding the correction value to an amplitude of the first pulse. Thus, the first pulse is corrected.




According to another feature of the fourth aspect of the invention, the correcting means further comprises means for determining a correction value based on the determined difference according to a predetermined expression, and adding the correction value to a value of the cuff pressure at a time of detection of the first pulse. Thus, the first pulse is corrected.




According to a fifth aspect of the present invention, there is provided an apparatus for measuring a propagation velocity of a pulse wave which is propagated through an artery of a living subject, the apparatus comprising, a blood-pressure measuring device which includes an inflatable cuff adapted to be wound around a body portion of the subject, a pulse-wave sensor which detects the pulse wave transmitted from the artery of the subject to the cuff when a pressure in the cuff is changed, and means for determining a blood pressure value of the subject based on the detected pulse wave, an electrocardiographic-waveform detecting device which includes a plurality of electrodes adapted to contact a body surface of the subject and which detects an electrocardiographic waveform from the subject through the electrodes, time-difference determining means for determining a time difference between a first periodic point relating to the detected electrocardiographic waveform and a second periodic point on relating to the detected pulse wave, propagation-velocity determining means for determining a propagation velocity of the pulse wave based on the determined time-difference value, and terminating means for terminating a blood pressure measurement of the blood-pressure measuring device when the determined propagation-velocity value does not fall within a permission range.




In the case where the present invention is embodied with the BP measuring device which determines a BP value of the subject based on the pulse wave obtained when the cuff pressure is changed, the relationship of correspondence of pulse wave and cuff pressure (or blood pressure) may break for a certain reason during each BP measuring operation of the BP measuring device. Hence, if an abnormal event occurs during each BP measurement and the propagation velocity excessively changes, i.e., increases or decreases, the BP measurement is forcedly terminated. Thus, an inaccurate BP measurement or value is effectively avoided.




According to a preferred feature of the fifth aspect of the invention, the propagation velocity measuring apparatus further comprises a memory which stores data indicative of a plurality of the permission ranges corresponding to a plurality of values of the cuff pressure at which a plurality of propagation-velocity values are determined by the propagation-velocity determining means.




According to a sixth aspect of the present invention, there is provided an apparatus for measuring a propagation velocity of a pulse wave which is propagated through an artery of a living subject, the apparatus comprising, a first and a second heartbeat-synchronous-wave sensor which detect, as the pulse wave, a first and a second heartbeat-synchronous wave, respectively, each of which is produced from the artery of the subject in synchronism with a heartbeat of the subject, maximum-slope-line determining means for determining, with respect to at least one of the first and second waves, a maximum-slope line which passes through a maximum-slope point where a heartbeat-synchronous pulse of the one wave takes a maximum slope, such that the maximum-slope line has the maximum slope, base-line determining means for determining, with respect to the one wave, a base line which passes through respective minimum points on both sides of a maximum point of the heartbeat-synchronous pulse of the one wave, reference-point determining means for determining, as a reference point, a point of intersection of the maximum-slope line and the base line, and propagation-velocity determining means for determining the propagation velocity of the pulse wave based on a time difference between the reference point determined with respect to the heartbeat-synchronous pulse of the one wave and a corresponding heartbeat-synchronous pulse of the other of the first and second waves.




The pulse wave propagated through the artery of the subject contains, as a primary component, a travelling wave and additionally contains, as a secondary component, a reflected wave produced when the travelling wave is reflected by the wall of the artery, e.g., bifurcate wall, as illustrated in FIG.


25


. Since, generally, the component of the reflected wave is weak relative to the component of the travelling wave, the maximum point of each travelling wave can be estimated as the maximum point of each pulse wave. However, as the arterial sclerosis becomes worse, the component of the reflected wave becomes stronger, and the maximum point of each pulse wave is more influenced by the component of the reflected wave, as shown in FIG.


29


. If the maximum point of the pulse wave is used as a reference point for determining a pulse-wave propagation velocity, then the propagation velocity may largely change depending upon the degree of arterial sclerosis of the subject and/or the shape of the artery wall where the pulse wave is detected. In the pulse-wave propagation velocity measuring apparatus in accordance with the sixth aspect of the invention, however, the reference-point determining means determines, as the reference point, a point of intersection of the maximum-slope line and the base line. This reference point (T


S


) is free from the influences of the reflected wave, as illustrated in FIG.


25


. Thus, the reference point does not change or move relative to the pulse wave even if the subject may have a serious arterial sclerosis. Accordingly, the present apparatus measures, with high accuracy, the propagation velocity of the pulse wave.




According to a seventh aspect of the present invention, there is provided an apparatus for measuring a propagation velocity of a pulse wave which is propagated through an artery of a living subject, the apparatus comprising, a first and a second heartbeat-synchronous-wave sensor which detect, as the pulse wave, a first and a second heartbeat-synchronous wave, respectively, each of which is produced from the artery of the subject in synchronism with a heartbeat of the subject, maximum-slope-line determining means for determining, with respect to at least one of the first and second waves, a maximum-slope line which passes through a maximum-slope point where a heartbeat-synchronous pulse of the one wave takes a maximum slope, such that the maximum-slope line has the maximum slope, maximum-point-line determining means for determining, with respect to the one wave, a maximum-point line which passes through a maximum point where the heartbeat-synchronous pulse of the one wave takes a maximum amplitude, such that the maximum-point line is parallel to a base line which passes through respective minimum points on both sides of the maximum point of the heartbeat-synchronous pulse of the one wave, reference-point determining means for determining a reference point from a point of intersection of the one wave and a line which passes through a point of intersection of the maximum-slope line and the maximum-point line and is perpendicular to the maximum-point line, and propagation-velocity determining means for determining the propagation velocity of the pulse wave based on a time difference between the reference point determined with respect to the heartbeat-synchronous pulse of the one wave and a corresponding heartbeat-synchronous pulse of the other of the first and second waves.




In the pulse-wave propagation velocity measuring apparatus in accordance with the seventh aspect of the invention, the reference-point determining means determines the reference point from a point of intersection of the one wave and a line which passes through a point of intersection of the maximum-slope line and the maximum-point line and is perpendicular to the maximum-point line. The reference point may be determined as being equal to the point of intersection of the one wave and the line or otherwise be determined based on the intersection point. This reference point (T


S


) is free from the influences of the reflected wave, as illustrated in FIG.


29


. Thus, the reference point does not change or move relative to the pulse wave even if the subject may have a serious arterial sclerosis. Accordingly, the present apparatus measures, with high accuracy, the propagation velocity of the pulse wave.




According to an eighth aspect of the present invention, there is provided an apparatus for measuring a propagation velocity of a pulse wave which is propagated through an artery of a living subject, the apparatus comprising a first and a second heartbeat-synchronous-wave sensor which detect, as the pulse wave, a first and a second heartbeat-synchronous wave, respectively, each of which is produced from the artery of the subject in synchronism with a heartbeat of the subject, reference-point determining means for determining, with respect to at least one of the first and second waves, a maximum-slope point where a heartbeat-synchronous pulse of the one wave takes a maximum slope, and determining the determined maximum-slope point as a reference point, and propagation-velocity determining means for determining the propagation velocity of the pulse wave based on a time difference between the reference point determined with respect to the heartbeat-synchronous pulse of the one wave and a corresponding heartbeat-synchronous pulse of the other of the first and second waves.




In the pulse-wave propagation velocity measuring apparatus in accordance with the eighth aspect of the invention, the reference-point determining means determines, as the reference point, a maximum-slope point where the pulse wave takes a maximum slope. This reference point (K


max


) is free from the influences of the reflected wave, as illustrated in

FIG. 25

or


29


. Thus, the reference point does not change or move relative to the pulse wave even if the subject may have a serious arterial sclerosis. Accordingly, the present apparatus measures, with high accuracy, the propagation velocity of the pulse wave.











BRIEF DESCRIPTION OF THE DRAWINGS




The above and optional objects, features, and advantages of the present invention will better be understood by reading the following detailed description of the preferred embodiments of the invention when considered in conjunction with the accompanying drawings, in which:





FIG. 1

is a diagrammatic view of a blood pressure (BP) monitor apparatus providing a pulse-wave propagation velocity measuring apparatus as a first embodiment of the present invention;





FIG. 2

is a block diagram for illustrating essential functions of an electronic control device of the apparatus of

FIG. 1

;





FIG. 3

is a graph showing a relationship which is determined by the control device of the apparatus of

FIG. 1

;





FIG. 4

is a flow chart representing a control program according to which the apparatus of

FIG. 1

is controlled;





FIG. 5

is a time chart for illustrating a time difference, TD


RP


, which is determined by the control device of the apparatus of

FIG. 1

;





FIG. 6

is a diagrammatic view corresponding to

FIG. 1

, showing a BP measuring apparatus providing another pulse-wave propagation velocity measuring apparatus as a second embodiment of the present invention;





FIG. 7

is a block diagram corresponding to

FIG. 2

, for illustrating essential functions of an electronic control device of the apparatus of

FIG. 6

;





FIG. 8

is a perspective view of a BP measuring apparatus providing another pulse-wave propagation velocity measuring apparatus as a third embodiment of the present invention;





FIG. 9

is a diagrammatic view corresponding to

FIG. 1

, for showing the construction of of the apparatus of

FIG. 8

;





FIG. 10

is a block diagram corresponding to

FIG. 2

, for illustrating essential functions of an electronic control device of the apparatus of

FIG. 8

;





FIG. 11

is a flow chart representing a control program according to which the apparatus of

FIG. 8

is controlled;





FIG. 12

is a time chart for illustrating a time difference, TD


RP


, which is determined by the control device of the apparatus of

FIG. 8

;





FIG. 13

is a view of a printed sheet output from a printer of the apparatus of

FIG. 8

;





FIG. 14

is a map representing a relationship between degree of arterial sclerosis and modified pulse-wave propagation velocity V


M2


which is used for determining a degree of arterial sclerosis from a modified pulse-wave propagation velocity V


M2


;





FIG. 15

is a perspective view corresponding to

FIG. 8

, showing another BP measuring apparatus providing another pulse-wave propagation velocity measuring apparatus as a fourth embodiment of the present invention;





FIG. 16

is a block diagram corresponding to

FIG. 10

, for illustrating essential functions of an electronic control device of the apparatus of

FIG. 15

;





FIG. 17

is a time chart for illustrating a time difference, TD


RP


, which is determined by the control device of the apparatus of

FIG. 15

;





FIG. 18

is a graph showing the change of the propagation-velocity values V


M1


determined by the apparatus of

FIG. 15

, with respect to the pressure of an inflatable cuff of the same;





FIG. 19

is a graph showing the change of respective amplitudes of heartbeat-synchronous pulses of a pulse wave transmitted to the cuff, with respect to the cuff pressure;





FIG. 20

is a flow chart representing a control program according to which the apparatus of

FIG. 15

is controlled;





FIG. 21

is a flow chart representing an interrupt subroutine according to which the apparatus of

FIG. 15

is controlled;





FIG. 22

is a map representing a relationship between degree of arterial sclerosis and modified propagation velocity V


M3


that is used for determining a degree of arterial sclerosis from a modified propagation velocity V


M3


;





FIG. 23

is a block diagram corresponding to

FIG. 10

, for illustrating essential functions of an electronic control device of another BP measuring apparatus providing another propagation-velocity measuring apparatus as a fifth embodiment of the present invention;





FIG. 24

is a time chart for illustrating a time difference TD


RP


which is determined by the control device of the apparatus of

FIG. 23

;





FIG. 25

is an enlarged view for illustrating a reference point, T


S


, determined by the control device of the apparatus of

FIG. 23

;





FIG. 26

is a flow chart representing a control program according to which the apparatus of

FIG. 23

is controlled;





FIG. 27

is a flow chart representing an interrupt subroutine according to which the apparatus of

FIG. 23

is controlled;





FIG. 28

is a block diagram corresponding to

FIG. 23

, for illustrating essential functions of an electronic control device of another BP measuring apparatus providing another propagation-velocity measuring apparatus as a sixth embodiment of the present invention;





FIG. 29

is an enlarged view corresponding to

FIG. 25

, for illustrating a reference point T


S


determined by the control device of the apparatus of

FIG. 28

;





FIG. 30

is a flow chart representing an interrupt subroutine according to which the apparatus of

FIG. 28

is controlled;





FIG. 31

is a block diagram corresponding to

FIG. 23

, for illustrating essential functions of an electronic control device of another BP measuring apparatus providing another propagation-velocity measuring apparatus as a seventh embodiment of the present invention; and





FIG. 32

is a flow chart representing an interrupt subroutine according to which the apparatus of

FIG. 31

is controlled.











DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS




Referring first to

FIGS. 1 through 7

, there will be described a first embodiment of the present invention which relates to a blood-pressure (BP) monitor apparatus


8


which monitors the blood pressure of a living subject and which also functions as an apparatus for measuring a propagation velocity of a pulse wave which is propagated through an artery of the subject.




In

FIG. 1

, the BP monitor apparatus


8


includes a cuff


10


which has a belt-like cloth bag and a rubber bag accommodated in the cloth bag and which is adapted to be wound around, e.g., an upper arm


12


of a patient, and a pressure sensor


14


, a selector valve


16


, and a first air pump


18


each of which is connected to the cuff


10


via piping


20


. The selector valve


16


is selectively placed in an inflation position in which the selector valve


16


permits a pressurized air to be supplied from the air pump


18


to the cuff


10


, a slow-deflation position in which the selector valve


16


permits the pressurized air to be discharged slowly from the cuff


10


, and a quick-deflation position in which the selector valve


16


permits the pressurized air to be discharged quickly from the cuff


10


.




The pressure sensor


14


detects an air pressure in the cuff


10


, and supplies a pressure signal, SP, representing the detected pressure to each of a static-pressure filter circuit


22


and a pulse-wave filter circuit


24


. The static-pressure filter circuit


22


includes a low-pass filter and extracts, from the pressure signal SP, a static component contained in the signal SP, i.e., cuff-pressure signal, SK, representing the static cuff pressure. The cuff-pressure signal SK is supplied to an electronic control device


28


via a first A/D converter


26


.




The pulse-wave filter circuit


24


includes a band-pass filter and extracts, from the pressure signal SP, an oscillatory component having frequencies in a predetermined range, i.e., cuff-pulse-wave (CPW) signal, SM


1


. The CPW signal SM


1


is supplied to the control device


28


via a second A/D converter


30


. The CPW signal SM


1


represents a cuff pulse wave, i.e., oscillatory pressure wave which is produced from a brachial artery (not shown) of the patient in synchronism with the heartbeat of the patient and is propagated to the cuff


10


.




The electronic control device


28


is provided by a so-called microcomputer including a central processing unit (CPU)


29


, a read only memory (ROM)


31


, a random access memory (RAM)


33


, and an input and output (I/O) port (not shown). The CPU


29


processes input signals according to the control programs pre-stored in the ROM


31


by utilizing the temporary-storage function of the RAM


33


, and supplies drive signals via the I/O port to the selector valve


16


and the first air pump


18


.




The BP monitor apparatus


8


further includes a pressure-pulse-wave detecting probe


34


. The detecting probe


34


has a container-like housing


36


which is detachably worn, with the help of bands


40


, on a body surface


38


of a wrist


42


downstream of an upper arm of the patient different from the upper arm


12


around which the cuff


10


is wound, or wrist downstream of the upper arm


12


, such that an opening of the housing


36


is opposed to the body surface


38


. A pressure-pulse-wave (PPW) sensor


46


is supported by the housing


36


via a diaphragm


44


, such that the PPW sensor


46


is movable relative to the housing


36


and is advanceable through the opening of the housing


36


. The housing


36


, the diaphragm


44


, and the PPW sensor


46


cooperate with one another to define a pressure chamber


48


, to which a pressurized air is supplied from a second air pump


50


via a pressure regulator valve


52


. Thus, the PPW sensor


46


is pressed against a radial artery


56


via the body surface or skin


38


with a pressing force, P


HD


, corresponding to the air pressure in the pressure chamber


48


.




The PPW sensor


46


includes a number of semiconductor pressure-sensing elements (not shown) which are arranged in a pressing surface


54


of a semiconductor chip formed of, e.g., monocrystalline silicon. The PPW sensor


46


is pressed against the radial artery


56


via the body surface


38


of the wrist


42


to detect a pressure pulse wave (PPW), i.e., oscillatory pressure wave which is produced from the radial artery


56


and is transmitted thereto via the body surface


38


, and generates a pressure-pulse-wave (PPW) signal, SM


2


, representing the detected PPW. The PPW signal SM


2


is supplied to the control device


28


via a third A/D convertor


58


. In the present embodiment, the PPW sensor


46


provides a pulse-wave sensor which detects a pulse wave propagated through an artery of a living subject.




The CPU


29


of the control device


28


operates, according to the control programs pre-stored in the ROM


31


, for supplying drive signals to the second air pump


50


and the pressure regulator value


52


, and thereby regulating the air pressure in the pressure chamber


48


, that is, pressing force P


HD


Of the PPW sensor


46


applied to the radial artery


56


via the body surface


38


. Based on respective magnitudes of heartbeat-synchronous pulses of the PPW detected through the PPW sensor


46


while the air pressure of the chamber


48


is changed, the CPU


29


determines an optimum pressing force, P


HDP


, of the PPW sensor


46


, in a known manner, and controls the pressure regulator valve


52


to maintain the optimum pressing force or pressure P


HDP


, for each continuous BP monitoring operation.




The BP monitor apparatus


8


additionally includes an electrocardiographic-waveform (ECG-waveform) detecting device


60


. The ECG-waveform detecting device


60


continuously detects an electrocardiographic (ECG) waveform indicating the time-wise change of electric potential of the cardiac muscle of a living subject, through a plurality of electrodes


62


which are placed at predetermined positions on the subject. The ECG-waveform detecting device


60


may be provided by an electrocardiograph, and the ECG waveform may be an electrocardiogram detected by the electrocardiograph. The ECG-waveform detecting device


60


supplies an electric signal representing the detected ECG waveform, to the electronic control device


28


, so that the CPU


29


of the control device


28


processes the electric signal in a manner described later. A display device


32


may, not may not, record the ECG waveform on a recording sheet (not shown).




In an upper and a lower portion of the graph of

FIG. 5

, a waveform as an example of a pressure pulse wave (PPW) detected by the PPW sensor


46


, and an example (electrocardiogram) of an ECG waveform detected by the ECG-waveform detecting device


60


are shown, respectively.





FIG. 2

illustrates essential control functions of the electronic control device


28


of the BP monitor apparatus


8


. First, the control device


28


cooperates with the pressure sensor


14


, the filter circuits


22


,


24


, and the A/D converters


26


,


30


to function as a BP measuring means


72


which measures a systolic BP value, SBP, and a diastolic BP value, DBP, of the patient, according to a well-known oscillometric method (e.g., JIS T 1115; JIS is Japanese Industrial Standard), based on the variation of respective amplitudes of heartbeat-synchronous pulses of the cuff pressure wave (i.e., CPW signal SM


1


) obtained through the pulse-wave filter circuit


24


while the pressure of the cuff


10


is slowly increased or decreased. The measured BP values are displayed on a screen of a cathode ray tube (CRT) of the display device


32


.




The PPW sensor


46


is preferably pressed on the body surface


38


of the wrist


42


downstream of the upper arm different from the upper arm


12


on which the cuff


10


is worn, and detects a pressure pulse wave (PPW) produced from the radial artery


56


of the wrist


42


. The control device


28


functions as a relationship determining means


74


which determines, in advance, a relationship between BP value (i.e., monitor BP value, MBP) and magnitude, P


M


, of pressure pulse wave, based on at least one BP value measured by the BP measuring means


72


and at least one magnitude of the PPW (i.e., PPW signal SM


2


) detected by the PPW sensor


46


, for each patient and each BP monitoring operation. This relationship may be one, shown in

FIG. 3

, which is defined by the following linear function: MBP=A·P


M


+B, where A is a constant indicative of the slope of the linear function and B is a constant indicative of an intercept of the linear function. The control device


28


also functions as a monitor BP determining means


76


which successively determines, according to the relationship, a systolic and a diastolic BP value, MBP


SYS


, MBP


DIA


, (monitor BP values MBP), based on magnitudes P


M


of each heartbeat-synchronous pulse of the pressure pulse wave (i.e., PPW signal SM


2


) detected by the PPW sensor


46


, that is, maximum (upper-peak) and minimum (lower-peak) magnitudes, P


Mmax


, P


Mmin


, of each heartbeat-synchronous pulse of the pressure pulse wave, and successively outputs the determined monitor BP values MBP to the display device


32


so that the display device


32


successively displays the monitor BP values MBP for each heartbeat-synchronous pulse of the PPW.




The control device


28


also functions as a time-difference determining means


80


which determines a time difference between a predetermined periodic point relating to the ECG waveform of each of heartbeat-synchronous pulses of the electric signal supplied from the ECG-waveform detecting device


60


, and a predetermined periodic point relating to the PPW waveform of a corresponding one of heartbeat-synchronous pulses of the PPW signal SM


2


supplied from the PPW sensor


46


. For example, the determining means


80


determines a time difference, TD


RP


, between the time of occurrence or detection of an R wave of each pulse of the ECG waveform and the time of occurrence or detection of a maximum (upper-peak) point of a corresponding pulse of the PPW waveform, as shown in FIG.


5


. The maximum or upper-peak point has a maximum magnitude, i.e., maximum electric voltage.




The control device


28


additionally functions as a propagation-velocity determining means


82


which determines a propagation velocity, V


M


, (m/sec) of the pressure pulse wave (PPW) which is propagated through the artery of the patient including the radial artery


56


, based on the determined time difference TD


RP


, according to the following expression (1) pre-stored in the ROM


31


:








V




M




L/


(


TD




RP




−T




PEP


)  (1)






where




L is the length of the artery of the patient from the left ventricle to the position of pressing of the PPW sensor


46


via the aorta, brachial artery, and radial artery


56


; and




T


PEP


is the pre-ejection period between a Q wave or point of the ECG waveform and a minimum point (i.e., rising point) of the PPW waveform.




The values L, T


PEP


occurring in the expression (1) are experimentally determined, in advance.




Next, there will be described the operation of the BP monitor apparatus


8


constructed as described above, by reference to the flow chart of FIG.


4


.




First, at Step SA


1


, the CPU


29


of the control device


28


reads in one heartbeat-synchronous pulse of the ECG waveform detected by the ECG-waveform detecting device


60


and, at Step SA


2


, the CPU


29


reads in a corresponding heartbeat-synchronous pulse of the PPW waveform detected by the PPW sensor


46


.




Subsequently, at Step SA


3


, the CPU


29


judges whether the CPU


29


has read in an R wave (or R point) of the heartbeat-synchronous pulse of the ECG waveform. If a negative judgment is made at Step SA


3


, the control of the CPU


29


goes back to Step SA


1


. Meanwhile, if a positive judgment is made at Step SA


3


, the control of the CPU


29


goes to Step SA


4


to judge whether the CPU


29


has read in a maximum point of the corresponding heartbeat-synchronous pulse of the PPW waveform.




If a negative judgment is made at Step SA


4


, the control of the CPU


29


goes back to Step SA


1


. Meanwhile, if a positive judgment is made at Step SA


4


, the control of the CPU


29


goes to Step SA


5


to determine a time difference TD


RP


from the R wave of one pulse of the ECG waveform to the maximum point of corresponding pulse of the PPW waveform, as shown in FIG.


5


. Step SA


5


corresponds to the time-difference determining means


80


. Step SA


5


is followed by Step SA


6


to determine a propagation velocity V


M


of PPW, based on the time difference TD


RP


determined at Step SA


5


, according to the above expression (1). Step SA


6


corresponds to the propagation-velocity determining means


82


. The PPW propagation velocity V


M


determined at Step SA


6


may be used to estimate a degree of arterial sclerosis, a peripheral resistance, or a BP value of the patient according to an algorithm (not shown). The thus estimated BP value may be utilized by the relationship determining means


74


when the means


74


operates for updating the MBP-P


M


relationship shown in FIG.


3


.




As is apparent from the foregoing description, in the first embodiment shown in

FIGS. 1

to


5


, the CPU


29


of the control device


28


determines, at Step SA


5


, the time difference TD


RP


between the predetermined periodic point (R wave) of each heartbeat-synchronous pulse of the ECG waveform and the predetermined periodic point (maximum point) of a corresponding heartbeat-synchronous pulse of the PPW waveform and determines, at Step SA


6


, the velocity V


M


of propagation of the PPW through the artery of the patient, based on the time difference TD


RP


determined at Step SA


5


, according to the above expression (1). This propagation velocity V


M


is calculated based on the greatest length L of patient's artery including the aorta directly connected to patient's heart. In addition, since the aorta has the greatest diameter, the velocity V


M


of propagation of the PPW becomes the lowest when the PPW passes through the aorta. That is, it needs a long time for the PPW to pass through the aorta. Thus, the time difference TD


RP


is maximized. Therefore, the present BP monitor apparatus


8


, i.e., pulse-wave propagation velocity measuring apparatus


8


measures the propagation velocity V


M


of the PPW with higher accuracy than the prior apparatus which measures a propagation velocity of a pulse wave based on a smaller time difference. In addition, the propagation velocity V


M


may be relied upon for estimating, with higher accuracy, a degree of arterial sclerosis and/or a BP value of the patient.




In addition, in the first embodiment, the PPW sensor


46


is used for the two purposes, i.e., one for detecting, from the radial artery


56


, the magnitudes P


M


of each pulse of the PPW which are used by the monitor BP determining means


76


for successively determining the monitor BP values MBP according to the relationship shown in FIG.


3


and the other for detecting the time of occurrence of the maximum point of each pulse of the PPW which is used by the time-difference determining means


80


for determining the time difference TD


RP


. Accordingly, the total number of elements or parts of the present apparatus


8


is decreased and the production cost of the same


8


is reduced.




Referring next to

FIGS. 6 and 7

, there will be described a second embodiment of the present invention. The second embodiment relates to a blood pressure (BP) measuring apparatus


108


which has basically the same hardware construction as that of the BP monitor apparatus


108


shown in

FIGS. 1 and 2

but does not include the PPW detecting probe


34


, the third A/D converter


58


, the second air pump


50


, or the pressure regulator valve


52


. The same reference numerals as used in

FIGS. 1 and 2

are used to designate the corresponding elements or parts of the BP measuring apparatus


108


shown in

FIGS. 6 and 7

, and the description thereof is omitted.




In the second embodiment, a cuff


10


, a pressure sensor


14


, a pulse-wave filter circuit


24


, etc. cooperate with one another to provide a pulse-wave sensor which detects a pulse wave propagated through an artery of a patient. The pulse-wave sensor


10


,


14


,


24


detects, as the pulse wave, a cuff pulse wave (CPW) which is propagated through a brachial artery of an upper arm


12


of the patient and transmitted to the cuff


10


, and supplies a cuff-pulse-wave (CPW) signal, SM


1


, representing the detected CPW waveform, to an electronic control device


28


via a second A/D converter


30


. An example of the CPW waveform is shown in an upper portion of the graph of FIG.


12


.




As shown in

FIG. 7

, the control device


28


functions as a time-difference determining means


180


which determines a time difference, TD


RP


, between an R wave of each heartbeat-synchronous pulse of an ECG waveform detected by an ECG-waveform detecting device


60


and a maximum (upper-peak) point of a corresponding heartbeat-synchronous pulse of the cuff pulse wave (i.e., CPW signal SM


1


) detected by the pulse-wave sensor


10


,


14


,


24


. The control device


28


also functions as a propagation-velocity determining means


182


which determines a velocity, V


MCPW


, of the CPW propagated through patient's artery including the brachial artery, based on the time difference TD


RP


determined by the time-difference determining means


180


, according to the same expression as the previously-indicated expression (1).




Like the propagation velocity V


M


determined by the BP monitor apparatus


8


, the propagation velocity V


MCPW


is determined based on the great length L of patient's artery including the aorta directly connected to patient's heart. In addition, since the aorta has the great diameter, the velocity V


MCPW


of propagation of the CPW becomes very low when the CPW passes through the aorta. That is, it needs a long time for the CPW to pass through the aorta. Thus, the time difference TD


RP


is maximized. Therefore, the present BP measuring apparatus


108


, i.e., pulse-wave propagation velocity measuring apparatus


108


measures the propagation velocity V


MCPW


of the CPW with higher accuracy than the prior apparatus which measures a propagation velocity of a pulse wave based on a small time difference. In addition, the propagation velocity V


MCPW


can be relied upon for estimating, with higher accuracy, a degree of arterial sclerosis and/or a BP value of the patient.




In the second embodiment shown in

FIGS. 6 and 7

, the pulse-wave sensor, i.e., cuff


10


, pressure sensor


14


, pulse-wave filter circuit


24


, etc. are used for the two purposes, i.e., one for cooperating with a BP measuring means


72


to measure a systolic and a diastolic BP value of the patient and the other for detecting the time of occurrence of the maximum point of each pulse of the CPW which is used by the time-difference determining means


180


for determining the time difference TD


RP


. Accordingly, the total number of elements or parts of the present apparatus


108


is decreased and the production cost of the same


108


is reduced.




In each of the first and second embodiments, the time difference TD


RP


is calculated as the difference of the time of occurrence of R wave of each pulse of the ECG waveform and the time of occurrence of maximum point of a corresponding pulse of the PPW or CPW. However, it is possible to determine a time difference, TD, between a Q wave or a S wave of each pulse of the ECG waveform and a maximum or a minimum (lower-peak) point of a corresponding pulse of the PPW or CPW, or between the R wave of each pulse of the ECG waveform and the minimum point of a corresponding pulse of the PPW or CPW. The propagation velocity V


M


, V


MCPW


may be determined based on the time difference TD according to the expression (1).




In the expression (1) employed in each of the first and second embodiments, the pre-ejection period T


PEP


is defined as the difference of the time of occurrence of Q wave (Q point) of each pulse of the ECG waveform and the time of occurrence of minimum point (rising point) of a corresponding pulse of the PPW or CPW. However, it is possible to define the pre-ejection period T


PEP


as a time difference between the R wave (R point) or S wave (S point) of each pulse of the ECG waveform and the minimum point of a corresponding pulse of the PPW or CPW, because the Q, R, and S waves of each pulse are very near to one another in time on the ECG waveform. Alternatively, it is possible to define the pre-ejection period T


PEP


as a time difference between a periodic point relating to each pulse of the ECG waveform and a periodic point relating to a corresponding pulse of an aortic pulse wave, as shown in FIG.


17


. In the last case, too, the value T


PEP


may be experimentally determined and stored in the ROM


31


, in advance.




In each of the first and second embodiments, the pressure pulse wave (PPW) or the cuff pulse wave (CPW) is detected as the pulse wave of the patient. However, the pulse-wave sensor may be provided by a known photoelectric sensor including a light source which emits a light toward a body surface or skin tissue of a patient, and a light detecting element which detects the light transmitted through, or reflected from, the skin tissue of the patient and produces an electric signal representing, as a photoelectric pulse wave, the time-wise change of intensity of the detected light. The intensity of the light transmitted through, or reflected from, the skin tissue changes as the volume of blood flowing through the artery running in the skin tissue changes in synchronism with the heartbeat of the patient. For example, a so-called pulse oximeter that measures a blood oxygen saturation of a living subject includes a photoelectric sensor including a light source which emits two lights having different wavelengths, respectively, toward skin tissue of the subject and a light detecting element which detects the two lights each transmitted through, or reflected from, the skin tissue. The pulse oximeter determines a blood oxygen saturation of the subject based on the detected lights. In the latter case, the photoelectric sensor is used for the two purposes, i.e., one for detecting the two lights which are utilized for determining the blood oxygen saturation of the patient and the other for detecting the time of occurrence of a periodic point of each pulse of the photoelectric pulse wave which is utilized for determining a time difference TD based on the time of occurrence of the periodic point. Accordingly, the total number of elements or parts of the pulse oximeter is decreased and the production cost of the same is reduced, like the apparatus


8


,


108


.




Referring next to

FIGS. 8

to


14


, there will be described a third embodiment of the present invention which relates to an automatic blood pressure (BP) measuring apparatus


208


which automatically measures a BP value of a living subject and which also functions as an apparatus for measuring a propagation velocity of a pulse wave which is propagated through an artery of the subject.




In

FIG. 8

, reference numeral


210


designates a housing of the BP measuring apparatus


208


. The housing


210


includes a tunnel-like, cylindrical hollow portion which provides an arm receiver


214


into which a right arm


212


of the subject is inserted for measurement of his or her BP value or values. Inside the arm receiver


214


, an elongate belt


216


is supported such that the belt


216


takes a generally cylindrical shape. An inflatable cuff


215


which is provided by a flexible cloth bag and a rubber bag accommodated in the cloth bag, is secured to the inner surface of the elongate belt


216


.




In rear of the arm receiver


214


, a first arm rest


217


is provided at a tilt to support the forearm of the right arm


212


. A first electrode


218


of an electrocardiographic-waveform detecting device


270


(

FIG. 9

) is provided on an end portion of the arm rest


217


such that the electrode


218


contacts the back of the hand of the right arm


212


. The upper surface of the arm rest


217


has a shape suitable for supporting the entire forearm of the arm


212


such that the muscles between the elbow and the back of the hand are kept relaxed for detecting an accurate electrocardiographic waveform. A second arm rest


219


is provided on the left-hand side of the housing


210


, for supporting a left arm


13


of the subject, and a second electrode


218


is provided on a middle portion of the arm rest


219


such that the second electrode


18


contacts the left arm


13


. The two electrodes


18


cooperate with each other to detect the electrocardiographic waveform from the subject. Like the first arm rest


217


, the upper surface of the second arm rest


219


has a shape suitable for supporting the entire forearm of the left arm


213


such that the muscles between the elbow and the back of the hand are kept relaxed for detecting an accurate electrocardiographic waveform.




The BP measuring apparatus


208


has an operation panel


220


including a START switch


222


, a STOP switch


224


, a printer


226


, and a card insertion slot


228


. The BP measuring apparatus


208


further has a display panel


230


including a SBP display


232


, a DBP display


234


, a HR display


236


, and a date and time display


238


. The abbreviations “SBP”, “DBP”, and “HR” represent a systolic BP value, a diastolic BP value, and a heart-rate or pulse-rate value, respectively.





FIG. 9

shows the construction of the BP measuring apparatus


208


. In the figure, the inflatable cuff


215


is connected via piping


246


to a pressure sensor


240


, a selector valve


242


, and an air pump


244


. The selector valve


242


is selectively placed in an inflation position in which the selector valve


242


permits a pressurized air to be supplied from the air pump


244


to the cuff


215


, a slow-deflation position in which the selector valve


242


permits the pressurized air to be discharged slowly from the cuff


215


, and a quick-deflation position in which the selector valve


242


permits the pressurized air to be discharged quickly from the cuff


215


. The elongate belt


216


which takes a cylindrical shape in the arm receiver


214


and to which the inflatable cuff


215


is secured, is fixed at one of longitudinal ends thereof to the housing


210


and is connected at the other longitudinal end to a rotatable drum


250


which is driven or rotated by a direct-current (DC) motor


248


via reduction gears. The elongate belt


216


or the inflatable cuff


215


is tightened, and loosened, by the DC motor


248


.




The pressure sensor


214


detects an air pressure in the cuff


215


, and supplies a pressure signal, SP, representing the detected pressure to each of a static-pressure filter circuit


252


and a pulse-wave filter circuit


254


. The static-pressure filter circuit


252


includes a low-pass filter and extracts, from the pressure signal SP, a static component contained in the signal SP, i.e., cuff-pressure signal, SK, representing the static cuff pressure. The cuff-pressure signal SK is supplied to an electronic control device


258


via a first A/D converter


256


.




The pulse-wave filter circuit


254


includes a band-pass filter and extracts, from the pressure signal SP, an oscillatory component having frequencies in a predetermined range, i.e., cuff-pulse-wave (CPW) signal, SM


1


. The CPW signal SM


1


is supplied to the control device


258


via a second A/D converter


260


. The CPW signal SM


1


represents a cuff pulse wave, i.e., oscillatory pressure wave which is produced from a brachial artery (not shown) of the subject in synchronism with the heartbeat of the subject and is propagated to the cuff


215


. In the present embodiment, the cuff


215


, pressure sensor


240


, pulse-wave filter circuit


254


, etc. cooperate with one another to provide a pulse-wave sensor which detects a pulse wave propagated through an artery of a living subject.




The electronic control device


258


is provided by a so-called microcomputer including a central processing unit (CPU)


262


, a read only memory (ROM)


264


, a random access memory (RAM)


266


, and an input and output (I/O) port (not shown). The CPU


262


processes input signals according to the control programs pre-stored in the ROM


264


by utilizing the temporary-storage function of the RAM


266


, outputs a drive signal to the printer


226


, and outputs display signals to the displays


232


-


238


. When a BP measurement is carried out, the CPU


262


supplies a drive signal to the DC motor


248


to wind the cuff


215


around the right arm


212


of the subject being inserted in the arm receiver


214


, subsequently supplies a drive signal to the air pump


244


to inflate the cuff


215


and thereby press the upper arm


212


, and then supplies a drive signal to the selector valve


242


to reduce gradually or slowly the pressure of the cuff


215


, so that the CPU


262


obtains the pulse-wave signal SM


1


and the cuff-pressure signal SK from the pressure sensor


240


via the respective filters


252


,


254


during this cuff-pressure reducing operation, determines a systolic and a diastolic BP value SBP, DBP of the subject according to a known oscillometric BP measuring method based on the obtained signals SM, SK, and supplies display signals to the SBP and DBP displays


232


,


234


to display the determined BP values SBP, DBP, respectively.




In addition, the CPU


262


produces a set of BP data which represents the thus determined BP values SBP, DBP and a date and a time when those BP values are obtained, and stores the set of BP data in a BP-data storing area of a memory device


268


. The memory device


268


accumulatively stores a plurality of sets of BP data produced in a plurality of BP measuring operations. The memory device


268


may be provided by a well-known data storing device such as a magnetic disk, a magnetic tape, a volatile semiconductor memory, or a non-volatile semiconductor memory.




The BP measuring apparatus


208


includes the electrocardiographic-waveform (ECG-waveform) detecting device


270


. The ECG-waveform detecting device


270


continuously detects an electrocardiographic (ECG) waveform indicating the change of electric potential of the cardiac muscle of the subject, through the pair of electrodes


218


one of which contacts the back of the right hand


212


of the subject and the other of which contacts the left arm


213


of the same. The ECG-waveform detecting device


270


may be provided by an electrocardiograph, and the ECG waveform may be an electrocardiogram detected by the electrocardiograph. The detecting device


270


supplies an electric signal representing the detected ECG waveform, to the control device


258


, so that the CPU


262


of the control device


258


processes the electric signal. The printer


226


may, not may not, print out the ECG waveform on a recording sheet


290


(FIG.


13


).




In an upper and a lower portion of the graph of

FIG. 12

, a waveform as an example of a cuff pulse wave (CPW) detected by the pulse-wave sensor


215


,


240


,


254


, and an example (electrocardiogram) of an ECG waveform detected by the ECG-waveform detecting device


270


are shown, respectively.





FIG. 10

illustrates essential control functions of the electronic control device


258


of the BP measuring apparatus


208


. First, the control device


258


functions as a cuff-pressure regulating means


278


which switches the selector valve


242


to the inflation position and drives the air pump


244


, so as to increase quickly the pressure of the cuff


215


up to a predetermined target value, P


1


, (e.g., 180 mmHg), subsequently switches the valve


242


to the slow-deflation position so as to decrease slowly the cuff pressure and, after a BP measurement, switches the valve


242


to the quick-deflation position so as to decrease quickly the cuff pressure. In addition, the control device


258


functions as a BP measuring means


280


which cooperates with the cuff


215


, the pressure sensor


240


, etc. to measure a systolic BP value SBP and a diastolic BP value DBP of the subject, according to a well-known oscillometric method, based on the variation of respective amplitudes of heartbeat-synchronous pulses of the cuff pressure wave (i.e., CPW signal SM


1


) obtained through the pulse-wave filter circuit


254


while the pressure of the cuff


215


is slowly decreased. The control device


258


additionally functions as a pulse-rate measuring means


281


which cooperates with the cuff


215


, the pressure sensor


240


, etc. to measure a pulse-rate value HR of the subject from the interval of successive two heartbeat-synchronous pulses of the CPW.




The control device


258


also functions as a time-difference determining means


282


which determines a time difference between a predetermined periodic point relating to the ECG waveform of each of heartbeat-synchronous pulses of the electric signal supplied from the ECG-waveform detecting device


270


, and a predetermined periodic point relating to the waveform of a corresponding one of heartbeat-synchronous pulses of the CPW signal SM


1


which is supplied from the pressure sensor


240


when the pressure of the cuff


215


is around the diastolic BP value DBP of the subject. For example, the determining means


282


determines a time difference, TD


RP


, between the time of occurrence or detection of an R wave of each pulse of the ECG waveform and the time of occurrence or detection of a maximum point (upper-peak point) of a corresponding pulse of the CPW waveform, as shown in FIG.


12


.




The control device


258


additionally functions as a propagation-velocity determining means


284


which determines a propagation velocity, V


M1


, (m/sec) of the cuff pulse wave (CPW) which is propagated through the artery of the subject including the brachial artery of the right arm


212


, based on the determined time difference TD


RP


, according to a predetermined expression (2):








V




M1




=L


/(


TD




RP




−T




PEP


)  (2)






where




L is the length (m) of the artery of the subject from the left ventricle to the position of pressing of the cuff


215


via the aorta and the brachial artery; and




T


PEP


is the pre-ejection period between a Q wave or point of the ECG waveform and a minimum point (i.e., rising point) of the CPW waveform.




The values L, T


PEP


occurring in the expression (2) are experimentally determined, in advance. The expression (2) is pre-stored in the ROM


264


.




The control device


258


also functions as a propagation-velocity modifying means


286


which modifies the propagation velocity V


M1


determined by the propagation-velocity determining means


284


, to a modified propagation. velocity, V


M2


, (m/sec) corresponding to a predetermined BP value, BP


t


, and a predetermined pulse rate, HR


t


, based on. the diastolic BP value DSP measured by the BP measuring means


280


and the pulse rate HR measured by the pulse-rate measuring means


281


, according to a predetermined expression, (3):








V




M2




=V




M1




+A


(


BP




t




−DBP


)+


E


(


HR




t




−HR


)  (3)






where




A=B·V


M1


+C·DBP+D . . . (4); and




B, C, D, and E are constants.




The coefficient, A, occurring in the expression (3) is determined by a coefficient determining means


287


according to the above expression (4). The coefficient A increases as the propagation velocity V


M1


increases, and decreases as the diastolic BP value DBP increases. The control device


258


functions as the coefficient determining means


288


. The constant E occurring in the expression (3) and the constants B, C, D occurring in the expression (4) are experimentally pre-determined. The constant B is positive and the constant C is negative.




Hereinafter, there will be described the operation of the BP measuring apparatus


208


constructed as described above, by reference to the flow chart of FIG.


11


.




First, at Step SA


201


, the CPU


262


judges whether a magnetic card


274


has been inserted in a card reader


272


through the insertion slot


228


by a living person. If a negative judgment is made at Step SA


201


, the current cycle of this routine is ended. On the other hand, if a positive judgment is made at Step SA


201


, the control of the CPU


262


goes to Step SA


202


to read identification (ID) data which are magnetically recorded on the magnetic card


274


and which identify the person who carries the card


274


.




Step SA


202


is followed by Step SA


203


to judge whether the ID data read from the magnetic card


274


are identical with ID data registered in an ID-data storing area of the memory device


268


. The ID-data storing area has the memory capacity to store a number of sets of ID data corresponding to a number of magnetic cards


274


, i.e., a number of living persons. If a negative judgment is made at Step SA


203


, the control of the CPU


262


goes to Step SA


222


to eject the card


274


from the card reader


272


through the slot


228


. On the other hand, if a positive judgment is made at Step SA


203


, i.e., the ID data read from the card


274


are identical with registered ID data, the control of the CPU


262


goes to Step SA


204


to judge whether the START switch


222


has been operated to start a blood pressure (BP) measurement.




If the judgment made at Step SA


204


is negative, Step SA


204


is repeated until a positive judgment is made. Meanwhile, if a positive judgment is made at Step SA


204


, the control of the CPU


262


goes to Step SA


205


to switch the selector valve


242


to the inflation position thereof and drive the air pump


244


so as to increase the pressure, P, of the cuff


215


up to a predetermined target value (e.g., 180mmHg) and subsequently stop the air pump


244


. Step SA


205


is followed by Step SA


206


to switch the valve


242


to the slow-deflation position so as to start the slow deflation of the cuff, i.e., slow decreasing of the cuff pressure P. Steps SA


205


and SA


206


correspond to the cuff-pressure regulating means


278


.




Step SA


206


is followed by Step SA


207


to judge whether the CPU


262


has read in one heartbeat-synchronous pulse of the CPW signal SM


1


. Step SA


207


is repeated until a positive judgment is made. Meanwhile, if a positive judgment is made at Step SA


207


, the control of the CPU


262


goes to Step SA


208


to effect a BP measuring subroutine in which a systolic, a diastolic, and a mean BP value SBP


1


, DBP


1


, MBP


1


, and a pulse-rate value HR


1


, of the person are measured. More specifically described, the BP values SBP


1


, DBP


1


, MBP


1


of the person are determined based on the signals SM


1


, SK obtained during the slow decreasing of the cuff pressure P, in the known oscillometric method. The systolic and diastolic BP values SBP


1


, DBP


1


are determined based on the variation of respective magnitudes of heartbeat-synchronous pulses of the CPW signal SM


1


obtained during the slow cuff-pressure decreasing. The mean BP value MBP


1


is determined as being equal to the cuff pressure at the time of occurrence or detection of a heartbeat-synchronous pulse having the greatest or maximum amplitude. The pulse-rate value HR


1


is determined from the time interval between the respective times of detection of two successive heartbeat-synchronous pulses of the CPW signal SM


1


. Step SA


208


corresponds to the BP measuring means


280


.




Step SA


208


is followed by Step SA


209


to judge whether a systolic BP value SBP


1


has been determined at Step SA


208


. If a negative judgment is made at Step SA


209


, the control of the CPU


262


goes back to Step SA


207


. On the other hand, if a positive judgment is made at Step SA


209


, the control of the CPU


262


goes to Step SA


210


to judge whether a diastolic BP value DBP


1


has been determined at Step SA


208


. If a negative judgment is made at Step SA


210


, the control of the CPU


262


goes back to Step SA


207


. Meanwhile, if a positive judgment is made at Step SA


210


, the control of the CPU


262


goes to Step SA


211


to store a set of BP data which represents the BP and pulse-rate values SBP


1


, DBP


1


, MBP


1


, HR


1


determined at Step SA


208


and the date and time of measurement of those values, in association with the ID data for the person, in the BP-data storing area of the memory device


268


. In addition, at Step SA


211


, the determined BP and pulse-rate values SBP


1


, DBP


1


, HR


1


are displayed on the SBP, DBP, and HR displays


232


,


234


,


236


, respectively.




Subsequently, at Step SA


212


, the CPU


262


of the control device


258


reads in one heartbeat-synchronous pulse of the ECG waveform detected by the ECG-waveform detecting device


270


and, at Step SA


213


, the CPU


262


reads in a corresponding heartbeat-synchronous pulse of the CPW waveform detected by the pressure sensor


240


. Next, at Step SA


214


, the CPU


262


judges whether the CPU


262


has read in an R wave (or R point) of the heartbeat-synchronous pulse of the ECG waveform. If a negative judgment is made at Step SA


214


, the control of the CPU


262


goes back to Step SA


212


. Meanwhile, if a positive judgment is made at Step SA


214


, the control of the CPU


262


goes to Step SA


215


to judge whether the CPU


262


has read in a maximum point of the corresponding heartbeat-synchronous pulse of the CPW waveform.




If a negative judgment is made at Step SA


215


, the control of the CPU


262


goes back to Step SA


212


. Meanwhile, if a positive judgment is made at Step SA


215


, the control of the CPU


262


goes to Step SA


216


to switch the selector valve


242


to the quick-deflation position so as to start the quick decreasing of the cuff pressure P. Step SA


216


corresponds to the cuff-pressure regulating means


278


. Step SA


216


is followed by Step SA


217


to determine a time difference TD


RP


between the R wave of one pulse of the ECG waveform and the maximum point of corresponding pulse of the CPW waveform, as shown in FIG.


12


. Step SA


217


corresponds to the time-difference determining means


282


. Step SA


217


is followed by Step SA


218


to determine a propagation velocity V


M1


of CPW, based on the time difference TD


RP


determined at Step SA


217


, according to the expression (2). Step SA


218


corresponds to the propagation-velocity determining means


284


.




Subsequently, at Step SA


219


, the CPU


262


determines a coefficient A occurring in the expression (3), based on the propagation velocity V


M1


determined at Step SA


218


and the diastolic BP value DBP


1


determined at Step SA


208


, according to the expression (4). Step SA


219


corresponds to the coefficient determining means


288


. Step SA


219


is followed by Step SA


220


to modify the propagation velocity V


M1


determined at Step SA


218


to a modified, i.e., normalized propagation velocity V


M2


corresponding to the predetermined BP value BP


t


and the predetermined pulse rate HR


t


, based on the diastolic BP value DBP


1


and the pulse rate HR


1


measured at Step SA


208


, according to the expression (3). Step SA


220


corresponds to the propagation-velocity modifying means


286


.




In addition, at Step SA


220


, the CPU


262


of the control device


258


determines a degree of arterial sclerosis, DAS, of the person based on the modified propagation velocity V


M2


according to a predetermined relationship between degree of arterial sclerosis and modified propagation velocity V


M2


, shown in

FIG. 14

, and store data indicative of the determined degree of arterial sclerosis DAS, together with the set of BP data stored at Step SA


211


, in the memory device


268


. The relationship shown in

FIG. 14

is experimentally pre-determined and is pre-stored in the ROM


264


. As the degree of arterial sclerosis increases, the flexibility or softness of the arteries of the person decreases.




Step SA


220


is followed by Step SA


221


to command the printer


226


to output or record, on a recording sheet


290


, the sets of BP data stored in the BP-data storing area of the memory device


268


, as shown in FIG.


13


. More specifically described, in an upper, left-hand portion of the sheet


290


, the printer


226


records a name


292


of the person identified by the ID data or card


274


. The name


292


of the person is represented by the registered ID data identifying the person. Bellow the name


292


, the printer


226


records (a) a data list


294


showing the dates and times of measurements, the measured BP and pulse-rate values SBP, DBP, HR, and the determined degrees of arterial sclerosis DAS which have accumulatively been stored in the memory device


268


; and (b) a graphic representation


296


of the sets of BP data and the sets of arterial-sclerosis data accumulatively stored in the memory device


268


. The graphic representation


296


shows, along a common axis of abscissa


298


indicative of time, a series of vertical bars each of which has a top and a bottom horizontal segment which represent a systolic and a diastolic BP value SBP, DBP, respectively, a series of white triangles each of which represents a pulse-rate value HR, and a series of black circles each of which represents a degree of arterial sclerosis DAS, in the order of measurement or determination. Step SA


221


is followed by Step SA


222


to eject the magnetic card


274


from the card reader


272


.




As is apparent from the foregoing description, in the third embodiment shown in

FIGS. 8

to


14


, the CPU


262


of the control device


258


determines, at Step SA


217


, the time difference TD


RP


between the predetermined periodic point (R wave) of each heartbeat-synchronous pulse of the ECG waveform and the predetermined periodic point (maximum point) of a corresponding heartbeat-synchronous pulse of the CPW waveform and determines, at Step SA


218


, the velocity V


M1


of propagation of the CPW through the artery of the subject, based on the time difference TD


RP


determined at Step SA


217


, according to the expression (2). In addition, at Step SA


220


, the CPU


262


modifies the propagation velocity V


M1


determined at Step SA


218


to the modified propagation velocity V


M2


corresponding to the predetermined BP value BP


t


and the predetermined pulse rate HR


t


, based on the diastolic BP value DBP


1


and the pulse rate HR


1


measured at Step SA


208


, according to the expression (3). Thus, even if the BP or pulse-rate values obtained from a living person in a plurality of measurements may differ from each other, the present apparatus


208


modifies each measured propagation velocity V


M1


to a modified propagation velocity V


M2


corresponding to the predetermined BP and pulse-rate values. Therefore, a series of modified propagation velocities V


M2


can directly be used as an index indicative of a time-wise change of the degree of arterial sclerosis of the person.




In addition, since the modified propagation velocity V


M2


corresponds to both the predetermined BP and pulse-rate values BP


t


, HR


t


, the value V


M2


is more accurate than a value, V


M2


′, which corresponds to only the predetermined BP value BP


t


and is obtained according to the following expression (5):








V




M2




′=V




M1




+A


(


BP




t




−DBP


)  (5)






The value V


M2


is free from the influences or fluctuations due to the change of pulse rate HR of the person, whereas the value V


M2


′ is subject to those fluctuations.




In the present apparatus


208


, the modified propagation velocity V


M2


is calculated using the coefficient A which is calculated, at Step SA


219


, based on the propagation velocity V


M1


determined at Step SA


218


and the diastolic BP value DBP


1


determined at Step SA


208


, according to the expression (4). Owing to the coefficient A, the value V


M2


is free from the influences or fluctuations due to the differences of individual persons with respect to the degree of arterial sclerosis. Therefore, the values V


M2


obtained from different persons can be compared with each other for comparing the respective degrees of arterial sclerosis of those persons.




In the present apparatus


208


, the propagation velocity V


M1


or the modified propagation velocity V


M2


is obtained concurrently when the BP values SBP


1


, DBP


1


, MBP


1


are measured, and a series of values V


M2


can directly be used as an index indicative of a time-wise change of the degree of arterial sclerosis DAS. Thus, the person is provided with more physical information, with which he or she can think about his or her physical condition from more points of view. In addition, since the present apparatus


208


outputs the graphical representation


296


including the time-wise trend of DAS values, the person can easily and accurately see the time-wise change of the same.




In a conventional method, the pulse-wave propagation velocity is measured using a pulse-wave sensor which is applied, with the help of an exclusive assisting member, to a carotid artery or a femoral artery of a living subject. Thus, only the skilled person can fix the best condition under which the pulse-wave sensor is pressed against the artery via the skin, and it is considerably difficult for the subject himself or herself to measure his or her own propagation velocity. On the other hand, the present apparatus


208


can easily be operated by the subject without any skill to do so.




In the third embodiment, the time difference TD


RP


is determined, at Step SA


216


, based on the cuff pulse wave (i.e., CPW signal SM


1


) detected through the pressure sensor


240


when the pressure of the cuff


215


is changed around the diastolic BP value DBP


1


of the person. Generally, in a time duration in which the cuff pressure is higher than the mean BP value MBP


1


, the time difference TD


RP


increases as the cuff pressure decreases, as shown in FIG.


18


. However, when the cuff pressure is around the diastolic BP value DBP


1


, the time difference TD


RP


is not influenced by the change of the cuff pressure. Thus, the present apparatus


208


calculates a very accurate time difference TD


RP


and, accordingly, calculates a very accurate propagation velocity V


M1


, V


M2


.




In the third embodiment, the arm receiver


214


is adapted to receive the right arm


212


of the subject. However, it is possible to modify the arm receiver


214


to receive the left arm


213


. In the latter case, the receiver


214


and the first arm rest


217


are provided on a left half portion of the housing


210


, and the second arm rest


219


is provided on the right-hand side of the housing


210


. Although the first arm rest


217


is provided at a tilt, the rest


217


may be provided to extend in a horizontal direction. The second arm rest


219


may be provided at a tilt. In any case, the arm rests


217


,


219


are required to support the arms


212


,


213


such that the muscles of the arms


212


,


213


are kept relaxed.




Although, in the third embodiment, the first electrode


18


is provided on the free-end portion of the first arm rest


217


and the second electrode


18


is provided on the middle portion of the second arm rest


219


, it is possible to dispose the electrodes


18


at different positions depending upon the shapes and positions of the rests


217


,


219


. In any case, the electrodes


18


are required to detect a stable or accurate ECG waveform from the arms


212


,


213


of the person.




While in the third embodiment the degree of arterial sclerosis DAS is determined from the modified propagation velocity V


M2


corresponding to both the predetermined BP value BP


t


and the predetermined pulse rate HR


t


, it is possible that the value DAS be determined from the modified propagation velocity V


M2


′ which corresponds to only the predetermined BP value BP


t


and is calculated according to the expression (5). Since the pulse rate HR less influences the propagation velocity V


M1


than the blood pressure BP, the modified propagation velocity V


M2


′ can be relied upon to determine the value DAS.




Although the BP measuring apparatus


208


employs the automatic winding device


216


,


248


,


250


which automatically winds the cuff


215


around the upper arm


212


of the person, the apparatus


208


may employ a different cuff which can be wound around the right arm


212


with the hand of the left arm


213


of the person.




The coefficient A calculated according to the expression (4) may be replaced by a coefficient, A′, calculated according to the following expression (6):








A′=


(


B′·V




M1


)/(


C′·DBP


)+


D′


  (6)






The coefficient A′ is variable in direct proportion to the propagation velocity V


M1


determined at Step SA


218


and in reciprocal proportion to the diastolic BP value DBP


1


determined at Step SA


208


.




In the third apparatus


208


, the printer


226


records, on the recording sheet


290


, the data list


294


and the graphical representation


296


each of which contains the DAS (degree of arterial sclerosis) values. However, the printer


206


may be modified to record, in place of the DAS values, the modified propagation-velocity values V


M2


in one or each of the list


294


and the graph


296


.




Although the third apparatus


208


determines BP values based on the variation of respective amplitudes of heartbeat-synchronous pulses of the CPW obtained during the slow decreasing of the cuff pressure, it is possible to modify the apparatus


208


to determine BP values based on the variation of respective amplitudes of heartbeat-synchronous pulses of a CPW obtained during a low-rate increasing of the cuff pressure.




While the third apparatus


208


measures BP values according to an oscillometric method, the principle of the present invention may be applied to a BP measuring apparatus which measures BP values according to a well-known Korotkoff-sound method.




Referring next to

FIGS. 15

to


22


, there will described a fourth embodiment of the present invention which relates to an automatic BP measuring apparatus


308


which automatically measures a BP value of a living subject and which also functions as an apparatus for measuring a propagation velocity of a pulse wave which is propagated through an artery of the subject.




The BP measuring apparatus


308


as the fourth embodiment has substantially the same hardware construction as the BP measuring apparatus


208


as the third embodiment shown in

FIGS. 8 and 9

. The same reference numerals as used in

FIGS. 8 and 9

are used to designate the corresponding elements or parts of the fourth apparatus


308


, and the description thereof is omitted from the following description.




However, the fourth apparatus


308


has a first and a second electrode


318


,


318


and a first and a second arm rest


317


,


318


which are different from those


218


,


218


,


217


,


219


of the third apparatus


208


.




In addition, as shown in

FIG. 16

, an electronic control device


258


of the fourth apparatus


308


has different control functions


380


,


382


,


384


,


386


,


387


,


388


,


389


,


393


(


390


,


392


),


394


in addition to the same control function


278


as that


278


of the control device


258


of the third apparatus


208


shown in FIG.


10


. The fourth apparatus


308


is controlled according to the control program represented by the flow charts of

FIGS. 20 and 21

, in place of the control program represented by the flow chart of FIG.


11


. However, the main routine represented by the flow chart of

FIG. 20

has the same steps, Steps SA


201


through SA


207


, SA


216


, SA


221


, and SA


222


, as those SA


201


-SA


207


, SA


216


, SA


221


, SA


222


of the control program represented by the flow chart of FIG.


11


. The description of those steps is omitted from the following description.




The following description relates to only the differences of the fourth apparatus


308


from the third apparatus


208


.




In the fourth apparatus


308


, a first electrode


318


of an ECG-waveform detecting device


270


is provided on an end portion of a first arm rest


317


such that the first electrode


318


contacts the back of the wrist of a right arm


212


of a living subject. The upper surface of the arm rest


317


has a shape suitable for supporting the entire portion of the right arm


212


between the elbow and the wrist such that the muscles between the elbow and the wrist are kept relaxed for detecting an accurate ECG waveform from the subject. A second arm rest


319


is provided on the left-hand side of a housing


210


, for supporting a left arm


213


of the subject, and a second electrode


318


is provided on an end portion of the arm rest


319


such that the second electrode


318


contacts the wrist of the left arm


213


. The two electrodes


318


cooperate with each other to detect the electrocardiographic waveform from the subject. Like the first arm rest


317


, the upper surface of the second arm rest


319


has a shape suitable for supporting the entire portion of the left arm


213


between the elbow and the wrist such that the muscles between the elbow and the wrist are kept relaxed for detecting an accurate ECG waveform.




The ECG-wave detecting device


270


detects the ECG waveform of the subject through the two electrodes


318


held in contact with the respective wrists of the right and left arms


212


,


213


of the subject. An example of the ECG waveform detected through the electrodes


318


is shown in an upper portion of the graph of FIG.


17


. An example of a cuff pulse wave (CPW) waveform detected through a cuff


215


and a pressure sensor


240


is shown in a lower portion of the graph of FIG.


17


.





FIG. 16

illustrates essential control functions of the control device


258


of the fourth apparatus


308


. The control device


258


functions as a cuff-pressure regulating means


278


which is the same as the cuff-pressure regulating means


278


of the third apparatus


208


shown in FIG.


10


.




The control device


258


of the fourth apparatus


308


functions as a BP measuring means


380


which is basically the same as the BP measuring means


280


of the third apparatus


208


shown in FIG.


10


. However, one or more heartbeat-synchronous pulses of the CPW based on which the BP measuring means


380


measures BP values SBP, DBP, MBP of the subject, is or are corrected by a pulse correcting means


393


described later, as illustrated in FIG.


19


.




The control device


258


of the third apparatus


308


additionally functions as a time-difference determining means


382


which successively determines a time difference between a predetermined periodic point relating to the ECG waveform of each of heartbeat-synchronous pulses of an electric signal supplied from the ECG-waveform detecting device


270


, and a predetermined periodic point relating to the CPW waveform of a corresponding one of heartbeat-synchronous pulses of a CPW signal SM


1


which is supplied from the pressure sensor


240


when the pressure of the cuff


215


is changed around a diastolic BP value DBP of the subject. In the present embodiment, the determining means


382


determines a time difference, TD


RP


, between the time of occurrence or detection of an R wave of each pulse of the ECG waveform and the time of occurrence or detection of a minimum point (lower-peak point) of a corresponding pulse of the CPW waveform, as shown in FIG.


17


. In the present embodiment, the predetermined periodic point relating to the CPW waveform is defined as a rising point of each heartbeat-synchronous pulse, and the rising point may be defined as the minimum point, i.e., lower-peak point of each pulse. However, the rising point may otherwise be defined as a point greater than a minimum point by a predetermined magnitude, or a point where the slope or differential of the CPW waveform takes a maximum value. In short, the rising point may be defined as any periodic point other than a maximum (i.e. upper-peak) point of each pulse that is used by the time-difference determining means


282


of the third apparatus


208


.




The control device


258


of the fourth apparatus


308


functions as a temporary-propagation-velocity determining means


384


which determines a temporary propagation velocity V


M1


(m/sec) of CPW, based on each of the successively determined time-difference values TD


RP


, according to the same expression as the previously-indicated expression (2): V


M1


=L/(TD


RP


−T


PEP


). However, in the present embodiment, a pre-ejection period T


PEP


is defined as the time interval between the R wave of each pulse of the ECG waveform and the minimum point of a corresponding pulse of an aortic pulse wave produced from the aorta of the subject. This value T


PEP


is experimentally pre-determined and pre-stored in the ROM


264


.




In addition, the control device


258


of the fourth apparatus


308


functions as a stability judging means


386


which judges whether the propagation-velocity values V


M1


successively determined by the propagation-velocity determining means


384


have become stable, e.g., whether the amount or rate of change of the propagation-velocity values V


M1


has become not higher than a first or a second reference value, e.g., 0.1 m/sec or 3%, respectively; and as a proper-propagation-velocity determining means


387


which determines, as a proper propagation velocity, V


PM1


, of the subject, an average of a predetermined number of the propagation-velocity values V


M1


(corresponding to the level portion of a curve indicated at solid line in

FIG. 18

) which are determined by the propagation-velocity determining means


284


and are not higher than the first or second reference value. This number is counted by the CPU


262


from the first value V


M1


that first becomes not higher than the first or second reference value. However, the first value V


M1


itself may be determined as the proper propagation-velocity value V


PM1


.




The control device


258


of the fourth apparatus


308


also functions as a propagation-velocity modifying means


389


which modifies the proper propagation velocity V


PM1


determined by the proper-propagation-velocity determining means


387


, to a modified (i.e., normalized) proper propagation velocity V


M3


(m/sec) corresponding to a predetermined (i.e., normalized) BP value BP


t


(e.g.,


80


mmHg) and a predetermined pulse rate HR


t


(e.g., 70 BPM (beats per minute)), based on the diastolic BP value DBP measured by the BP measuring means


380


and a measured pulse rate HR, according to the following expression (7) similar to the expression (3):








V




M3




=V




PM1




+A


(


BP




t




−DBP


)+


E


(


HR




t




−HR


)  (7)






where




A=B·V


PM1


+C·DBP+D . . . (8); and




B, C, D, and E are constants.




The coefficient A occurring in the expression (7) is determined by a coefficient determining means


388


according to the above expression (8). The coefficient A increases as the propagation velocity V


PM1


increases, and decreases as the diastolic BP value DBP increases. The control device


258


of the fourth apparatus


308


functions as the coefficient determining means


388


. The constant E occurring in the expression (7) and the constants, B, C, D, occurring in the expression (8) are experimentally determined in advance. The constant B is positive and the constant C is negative.




In addition, the control device


258


of the fourth apparatus


308


functions as a propagation-velocity estimating means


390


which estimates, as the next propagation-velocity value, V


M1


′, (corresponding to a white triangle shown in

FIG. 18

) which will next be determined by the propagation-velocity determining means


384


, an average of a predetermined number of the propagation-velocity values V


M1


(corresponding to the level portion of the curve indicated at solid line in

FIG. 18

) which are determined by the propagation-velocity determining means


384


and are not higher than the first or second reference value, according to a predetermined expression (9):








V




M1


′=[(


V




M1


)i−n+ . . . +(


V




M1


)i−1+(


V




M1


)i]/(


n+


1)  (9)






This number is counted by the CPU


262


from the first value V


M1


that first becomes not higher than the first or second reference value. However, the last value V


M1


itself may be estimated as the next propagation-velocity value V


M1


′.




Moreover, the control device


258


of the fourth apparatus


308


functions as a correcting means


392


which calculates a difference, ΔV


M1


, of the next propagation-velocity value V


M1


′ estimated by the estimating means


390


and the next, actual propagation-velocity value V


M1


(corresponding to a black circle shown in

FIG. 18

) which is actually determined by the determining means


384


, according to a predetermined expression (10):






Δ


V




M1




=V




M1




′−V




M1


  (10)






The correcting means


392


additionally calculates a first correction value, X


1


, according to a predetermined expression (11):








X




1




=F·


(


ΔV




M1


)  (11)






where




F is a positive constant which is experimentally determined in advance.




The first correction value X


1


, indicated at broken line in

FIG. 19

, is added to the amplitude, indicated at solid line, of one heartbeat-synchronous pulse of CPW from which the current propagation-velocity value V


M1


(i.e., above-indicated next value V


M1


) is determined.




Alternatively, the correcting means


392


calculates a second correction value, X


2


, according to a predetermined expression (12):








X




2


=−G·(


ΔV




M1


)  (12)






where




G is a positive constant which is experimentally determined in advance.




The second correction value X


2


is added to the cuff-pressure value at the time of occurrence or detection of one heartbeat-synchronous pulse of CPW from which the current propagation-velocity value V


M1


(i.e., above-indicated next value V


M1


) is determined, so that the amplitude, indicated at solid line, of the pulse is moved to an amplitude indicated at broken line. The propagation-velocity estimating means


390


and the correcting means


392


cooperate with each another to provide a pulse correcting means


393


which correct the pulses of CPW, as needed. The corrected CPW pulses are utilized by the BP measuring means


380


for measuring the BP values of the subject.




Furthermore, the control device


258


of the fourth apparatus


308


functions as a BP-measurement terminating means


394


which terminates the current BP measuring operation of the BP measuring means


380


, if the current propagation-velocity value V


M1


determined by the determining means


384


does not fall within a permission range indicated at one-dot chain line in FIG.


18


. This permission range is experimentally pre-determined for all the values that can be taken by the cuff pressure, and pre-stored in the ROM


264


. However, it is possible to determine the permission range based on the propagation-velocity values V


M1


determined by the determining means


384


prior to the current value V


M1


, for example, the estimated value V


M1


′. In either case, the upper and lower limits of each permission range may be determined by a statistical technique such that it is almost impossible for a corresponding value V


M1


to fall outside the range.




Hereinafter, there will be described the operation of the BP measuring apparatus


308


constructed as described above, by reference to the flow charts of

FIGS. 20 and 21

.




Steps SA


201


to SA


207


of

FIG. 20

are the same as those SA


201


to SA


207


of FIG.


11


.




At Step SA


308


, a CPU


262


of the control device


258


determines a systolic, a diastolic, and a mean BP value SBzp


1


, DBP


1


, MBP


1


and a pulse-rate value HR in the same manner as that employed at Step SA


208


of FIG.


11


. However, one or more heartbeat-synchronous pulses of the CPW that is utilized by by the BP measuring means


380


may be corrected at Step SB


313


described later.




Step SA


308


is followed by Step SA


309


to judge whether a systolic BP value SBP


1


and a diastolic BP value DBP


1


have been determined at Step SA


308


. If a negative judgment is made at Step SA


309


, the control of the CPU


262


of the control device


258


of the fourth apparatus


308


goes back to Step SA


207


. On the other hand, if a positive judgment is made at Step SA


309


, the control of the CPU


262


goes to Step SA


310


to store a set of BP data which represents the BP and pulse-rate values SBP


1


, DBP


1


, MBP


1


, HR


1


determined at Step SA


308


and the date and time of measurement of those values, in association with ID data identifying a magnetic card


274


, i.e., a living person carrying the card


274


, in a BP-data storing area of a memory device


268


. In addition, at Step SA


310


, the determined BP and pulse-rate values SBP


1


, DBP


1


, HR


1


are displayed on a SBP, a DBP, and a HR display


232


,


234


,


236


, respectively.




Step SA


310


is followed by Step SA


311


to determine, as a proper propagation velocity V


PM1


of the subject, an average of the first, second, and third temporary propagation-velocity values V


M1


which have first, second, and third become not higher than the first or second reference value and have been stored in a second memory area (described later) of a RAM


266


of the control device


258


of the fourth apparatus


308


. Step SA


311


corresponds to the proper-propagation-velocity determining means


387


.




Step SA


311


is followed by Step SA


312


to determine a coefficient A occurring in the expression (7), based on the proper propagation-velocity value V


PM1


determined at Step SA


311


and the diastolic BP value DBP


1


determined at Step SA


308


, according to the expression (8). Step SA


312


corresponds to the coefficient determining means


388


. Step SA


312


is followed by Step SA


313


to modify the proper propagation velocity V


PM1


determined at Step SA


311


to a modified, i.e., normalized proper propagation velocity V


M3


corresponding to the predetermined BP value BP


t


and the predetermined pulse rate HR


t


, based on the diastolic BP value DBP


1


and the pulse rate HR


1


measured at Step SA


308


, according to the expression (7). Step SA


313


corresponds to the propagation-velocity modifying means


389


.




In addition, at Step SA


313


, the CPU


262


of the control device


258


of the fourth apparatus


308


determines a degree of arterial sclerosis DAS of the person based on the modified propagation velocity V


M3


according to a predetermined relationship between degree of arterial sclerosis and modified propagation velocity V


M3


, shown in

FIG. 22

, and store data indicative of the determined degree of arterial sclerosis DAS, together with the set of BP data stored at Step SA


310


, in the memory device


268


. The relationship shown in

FIG. 22

is experimentally pre-determined and is pre-stored in the ROM


264


. As the degree of arterial sclerosis increases, the flexibility or softness of the arteries of the person decreases.




Subsequently, at Step SA


216


, a selector valve


242


is switched to a quick-deflation position thereof so as to start the quick decreasing of the cuff pressure P. Step SA


216


corresponds to the cuff-pressure regulating means


278


. Step SA


216


is followed by Steps SA


221


and SA


222


which are the same as Steps SA


221


, SA


222


of FIG.


11


.




The flow chart of

FIG. 21

represents an interrupt subroutine which is implemented when the CPU


262


reads in the R wave of each heartbeat-synchronous pulse of the ECG waveform (i.e., electric signal) detected by the ECG-waveform detecting device


270


, while the main routine represented by the flow chart of

FIG. 20

is implemented. At Step SB


301


, the CPU


262


of the control device


258


of the fourth apparatus


308


specifies the time when the R wave of one pulse is detected or read in, and stores the specified time in the RAM


266


. Step SB


301


is followed by Step SB


302


to judge whether the CPU


262


has read in the lower-peak point of a corresponding pulse of the CPW waveform (i.e., CPW signal SM


1


) detected through the pressure sensor


240


. If a negative judgment is made at Step SB


302


, Step SB


302


is repeated until a positive judgment is made. Meanwhile, if a positive judgment is made at Step SB


302


, the control of the CPU


262


goes to Step SB


303


to specify the time when the lower-peak point of the corresponding pulse is detected or read in, and stores the specified time in the RAM


266


. Step SB


303


is followed by Step SB


304


.




At Step SB


304


, the CPU


262


determines a time difference TD


RP


between the time of detection of the R wave of the ECG waveform and the time of detection of the lower-peak point of the CPW waveform, as illustrated in FIG.


17


. Step SB


304


corresponds to the time-difference determining means


382


. Step SB


304


is followed by Step SB


305


to determine a temporary propagation velocity V


M1


of CPW, based on the time difference TD


RP


determined at Step SB


304


, according to the expression (2). The determined value V


M1


is stored in a first memory area of the RAM


66


. Step SB


305


corresponds to the temporary-propagation-velocity determining means


384


.




Subsequently, at Step SB


306


, the CPU


262


judges whether the current propagation-velocity value V


M1


determined at Step SB


305


falls within a predetermined permission range. This permission range has the upper and lower limits indicated at one-dot chain line in FIG.


18


. If a negative judgment is made at Step SB


306


, the control of the CPU


262


goes to Step SB


307


to switch the selector valve


242


to the quick-deflation position so as to start the quick deflation of the cuff


215


. Thus, the current BP measurement is terminated. Steps SB


306


and SB


307


correspond to the BP-measurement terminating means


394


. Step SB


307


is followed by Step SB


308


to control a printer


226


to print, on a recording sheet


290


, a message that another BP measurement should be tried and output the printed sheet. Then, at Step SB


309


, a magnetic card


274


is ejected through a card insertion slot


228


.




On the other hand, if a positive judgment is made at Step SB


306


, the control of the CPU


262


goes to Step SB


310


to judge whether the amount or rate of change of the current propagation-velocity value V


M1


determined in the current control cycle from the preceding value V


M1


determined in the preceding control cycle and stored in the first memory area of the RAM


266


is not greater than 0.1 m/sec or 3%. If a positive judgment is made at Step SB


310


, the control of the CPU


262


goes to Step SB


311


to store temporarily the current propagation-velocity value V


M1


determined at Step SB


305


in the current control cycle, in the second memory area of the RAM


266


. Step SB


310


corresponds to the stability judging means


386


.




Step SB


311


is followed by Step SB


312


to estimate a next propagation-velocity value V


M1


′ indicated at the white triangle in

FIG. 18

, based on the propagation-velocity values V


M1


stored in the second memory area of the RAM


266


, according to the expression (9). The estimated next value V


M1


′ is temporarily stored in a third memory area of the RAM


266


. Step SB


312


corresponds to the propagation-velocity estimating means


390


.




On the other hand, if a negative judgment is made at Step SB


310


, the control of the CPU


262


goes to Step SB


313


to determine a difference ΔV


M1


between the last estimated next propagation-velocity value V


M1


′ (indicated at the white triangle) that has last stored in the third memory area of the RAM


266


, and the current propagation-velocity value V


M1


(indicated at the black circle) which has been determined at Step SB


305


in the current control cycle, according to the expression (10), as illustrated in FIG.


18


. In addition, the CPU


262


determines a first correction value X


1


based on the determined difference ΔV


M1


according to the expression (11), or determines a second correction value X


2


based on the determined difference ΔV


M1


according to the expression (12). The first correction value X


1


is added to the amplitude of the pulse of CPW waveform from which the current value V


M1


has been derived, or the second correction value X


2


is added to the pressure of the cuff


215


at the time of detection of the pulse of CPW waveform from which the current value V


M1


has been derived. Thus, the CPW pulse is corrected and the corrected pulse is used by the BP measuring means


380


for carrying out the current BP measurement at Step SB


308


.




As is apparent from the foregoing description, in the fourth embodiment shown in

FIGS. 15

to


22


, the ECG-waveform detecting device


270


detects the ECG waveform through the electrodes


318


held in contact with the subject, and the pressure sensor


240


(i.e., pulse-wave sensor) detects the CPW waveform from the subject. The CPU


262


determines, at Step SB


304


, the time difference TD


RP


between the predetermined periodic point (R wave) of each heartbeat-synchronous pulse of the ECG waveform and the predetermined periodic point (lower-peak or minimum point) of a corresponding heartbeat-synchronous pulse of the CPW waveform and determines, at Step SB


305


, the velocity V


M1


of propagation of the CPW through the artery of the subject, based on the time difference TD


RP


determined at Step SB


304


. In addition, at Step SB


310


, the CPU


262


judges whether the change of each of the propagation-velocity values V


M1


from a corresponding preceding value V


M1


is smaller than a reference value and, at Step SA


311


, the CPU


262


determines, as a proper propagation-velocity value V


PM1


, an average of the first, second, and third values V


M1


for which the first, second, and third positive judgments are made, respectively, at Step SB


310


. Since the proper propagation-velocity value V


PM1


is determined based on the values V


M1


that are stable independent of the change of cuff pressure, the accuracy of measurement of pulse-wave propagation velocity is improved.




In addition, at Step SB


312


, the CPU


262


estimates, according to the expression (9), a next propagation-velocity value V


M1


′ which will next be determined at Step SB


305


, based on the propagation-velocity values V


M1


which have been determined at Step SB


305


and for each of which a positive judgment is made at Step SB


310


. Subsequently, at Step SB


313


, the CPU


262


determines the difference ΔV


M1


between the estimated next value V


M1


′ and the current value V


M1


determined at Step SB


305


in the current control cycle, according to the expression (10), and additionally determines the first correction value X


1


based on the determined difference ΔV


M1


according to the expression (11), or determines the second correction value X


2


based on the determined difference ΔV


M1


according to the expression (12). The first correction value X


1


is added to the amplitude of the pulse of CPW waveform from which the current value V


M1


has been derived, or the second correction value X


2


is added to the pressure of the cuff


215


at the time of detection of the pulse of CPW waveform from which the current value V


M1


has been derived. Thus, the CPW pulse is corrected and the corrected pulse is used at Step SB


308


for determining BP values in the current BP measurement. In this way, even in the case where the relationship of correspondence of pulse amplitude and cuff pressure (or blood pressure) breaks for a certain reason during each BP measurement, the pulse-amplitude value or the cuff-pressure value is advantageously corrected. Thus, the accuracy of measurement of BP values is improved.




Moreover, in the fourth apparatus


308


, at Step SB


306


, the CPU


262


judges whether each temporary propagation-velocity value V


M1


determined at Step SB


305


falls within the predetermined permission range having the upper and lower limits indicated at one-dot chain line in FIG.


18


. This permission range is experimentally pre-determined for all the values that can be taken by the pressure of the cuff


215


. If a negative judgment is made at Step SB


306


, the CPU


262


terminates the current BP measurement being carried out at Step SB


308


of

FIG. 20

, by quickly deflating the cuff


215


at Step SB


307


of the interrupt subroutine of FIG.


21


. Thus, if an abnormal event occurs during each BP measurement and the propagation velocity V


M1


takes an excessively high or low value, the BP measurement is ended. Therefore, inaccurate BP measurements are effectively avoided.




In the fourth embodiment, at Step SA


311


, the CPU


262


determines, as the proper propagation velocity V


PM1


, the average of the first three values V


M1


for each of which a positive judgment is made at Step SB


310


. However, the CPU


262


may be modified to determine, as the proper propagation velocity V


PM1


, the first value V


M1


for which the first positive judgment is made at Step SB


310


, or a different single value V


M1


for which a positive judgment is made at Step SB


310


. Alternatively, the CPU


262


may be modified to determine, as the proper propagation velocity V


PM1


, the average of two, four, or more values V


M1


for each of which a positive judgment is made at Step SB


310


.




In the fourth embodiment, at Step SB


312


, the CPU


262


estimates the next propagation-velocity value V


M1


′, based on the prior propagation-velocity values V


M1


stored in the second memory areas of the RAM


266


, according to the expression (9), i.e., determines, as the estimated value V


M1


′, a moving average of the values V


M1


stored in the second memory area of the RAM


266


. However, the CPU


262


may be modified to estimate the next value V


M1


′ by utilizing a statistical method, i.e., a regression line.




In the fourth apparatus


308


, the electrodes


318


provided on the arm rests


317


,


319


may be replaced by conventional suction-type electrodes adapted to be placed at predetermined positions on a living subject.




Referring next to

FIGS. 23

to


27


, there will described a fifth embodiment of the present invention which relates to an automatic BP measuring apparatus


408


which automatically measures a BP value of a living subject and which also functions as an apparatus for measuring a propagation velocity of a pulse wave which is propagated through an artery of the subject.




The BP measuring apparatus


408


as the fifth embodiment has the same hardware construction as the BP measuring apparatus


208


as the third embodiment shown in

FIGS. 8 and 9

. The same reference numerals as used in

FIGS. 8 and 9

are used to designate the corresponding elements or parts of the fifth apparatus


408


, and the description thereof is omitted from the following description.




However, as shown in

FIG. 23

, an electronic control device


258


of the fifth apparatus


408


has different control functions


482


,


484


,


486


,


488


,


490


,


492


,


494


,


496


,


497


in addition to the same control functions


278


,


280


as those


278


,


280


of the control device


258


of the third apparatus


208


shown in FIG.


10


. The fifth apparatus


408


is controlled according to the control program represented by the flow charts of

FIGS. 26 and 27

, in place of the control program represented by the flow chart of FIG.


11


. However, the main routine represented by the flow chart of

FIG. 26

has the same steps SA


201


through SA


208


, SA


216


, SA


221


, and SA


222


as those SA


201


-SA


208


, SA


216


, SA


221


, SA


222


of the control program represented by the flow chart of

FIG. 11

, and the same steps SA


309


, SA


310


as those SA


309


, SA


310


of the main routine of

FIG. 20

employed in the fourth apparatus


308


. The subroutine of

FIG. 27

has the same step SB


301


as that SB


301


of the subroutine of

FIG. 21

employed in the fourth apparatus


308


. The description of those steps is omitted from the following description.




The following description relates to only the differences of the fifth apparatus


408


from the third apparatus


208


or the fourth apparatus


308


.




In the present embodiment, an inflatable cuff


215


, a pressure sensor


240


, a pulse-wave filter circuit


254


, etc. cooperate with one another to provide one of a pair of heartbeat-synchronous-wave (HSW) sensors, and a cuff pulse wave (CPW) or a CPW signal SM


1


detected or provided by this HSW sensor corresponds to a heartbeat-synchronous wave (HSW) which is produced from an artery of a living subject in synchronism with the heartbeat of the subject.




In addition, in the present embodiment, an electrocardiographic-waveform (ECG-waveform) detecting device


270


and two electrodes


218


cooperate with one another to provide the other of the pair of HSW sensors, and an ECG waveform detected by this HSW sensor corresponds to another HSW.




The ECG-wave detecting device


270


detects the ECG waveform of the subject through the two electrodes


218


respectively held in contact with a right and a left arm


212


,


213


of the subject. An example of the ECG waveform represented by an electric signal supplied from the detecting device


270


is shown in an upper portion of the graph of FIG.


24


. An example of the CPW waveform detected through the pressure sensor


240


is shown in a lower portion of the graph of FIG.


24


.





FIG. 23

illustrates essential control functions of the control device


258


of the fifth apparatus


408


. The control device


258


functions as a cuff-pressure regulating means


278


and a BP measuring means


280


which are the same as the cuff-pressure regulating means


278


and the BP measuring means


280


, respectively, of the third apparatus


208


shown in FIG.


10


.




The control device


258


of the fifth apparatus


408


additionally functions as a time-difference determining means


482


which successively determines a time difference between a predetermined periodic point relating to the ECG waveform of each of heartbeat-synchronous pulses of the electric signal supplied from the ECG-waveform detecting device


270


, and a predetermined periodic point relating to the CPW waveform of a corresponding one of heartbeat-synchronous pulses of the CPW signal SM


1


which is supplied from the pressure sensor


240


when the pressure of the cuff


215


is changed around a diastolic BP value DBP of the subject. In the present embodiment, the determining means


482


determines a time difference, TD


RP


, between the time of occurrence or detection of an R wave of each pulse of the ECG waveform and the time of occurrence or detection of a reference point, T


S


, which is determined, as described later, with respect to a corresponding pulse of the CPW waveform, as shown in FIG.


24


.




The control device


258


of the fifth apparatus


408


functions as a temporary-propagation-velocity determining means


484


which successively determines a temporary propagation velocity V


M1


(m/sec) of CPW, based on each of the successively determined time-difference values TD


RP


, according to the same expression as the previously-indicated expression (2): V


M1


=L/(TD


RP


−T


PEP


). In the present embodiment, the pre-ejection period T


PEP


is defined as a time interval (sec) between the R wave of ECG waveform and a reference point T


S


of an aortic pulse wave, as illustrated in FIG.


24


. The respective values of length L (m) and pre-ejection period T


PEP


are experimentally determined in advance.




In addition, the control device


258


of the fifth apparatus


408


functions as a maximum-slope-line determining means


486


which determines, with respect to each pulse of the CPW waveform, a maximum-slope line, L


Kmax


, (indicated at broken line in

FIG. 25

) which passes through a maximum-slope point, K


max


, where the CPW waveform takes a maximum slope, such that the maximum-slope line L


Kmax


has the maximum slope. More specifically described, the determining means


486


differentiates the CPW waveform and determines, as the maximum-slope point K


max


, a point where the differentiated waveform or curve takes a maximum value.




The control device


258


of the fifth apparatus


408


also functions as a base-line determining means


488


which determines, with respect to each pulse of the CPW waveform, a base line, BL, (indicated at one-dot chain line in

FIG. 25

) which passes through respective minimum points on both sides of a maximum point of each pulse of CPW. In the present embodiment, one of the two minimum points (i.e., left one in

FIG. 25

) detected before the maximum point is defined as the minimum point of the current pulse, and the other minimum point (i.e., right one) detected after the maximum point is defined as the minimum point of the next pulse of CPW. One pulse of CPW corresponds to one beat of the heart of the subject.




Further, the control device


258


of the fifth apparatus


408


also functions as a reference-point determining means


490


which determines, as the reference point T


S


, a point of intersection of the maximum-slope line L


Kmax


and the base line BL.




Moreover, the control device


258


of the fifth apparatus


408


functions as a stability judging means


492


, a proper-propagation-velocity determining means


494


, a propagation-velocity modifying means


497


, and a coefficient determining means


496


which are the same as those


386


,


387


,


389


,


388


of the fourth apparatus


308


shown in

FIG. 16

, and the description thereof is omitted.




Hereinafter, there will be described the operation of the BP measuring apparatus


408


constructed as described above, by reference to the flow charts of

FIGS. 26 and 27

.




Steps SA


201


to SA


208


of

FIG. 26

are the same as those SA


201


to SA


208


of FIG.


11


.




Steps SA


309


and SA


310


of

FIG. 26

are the same as those SA


309


, SA


310


of FIG.


20


.




Step SA


310


is followed by Step SA


411


to determine, as a proper propagation velocity V


PM1


of the subject, an average of the first, second, and third temporary propagation-velocity values V


M1


which have first, second, and third become not higher than a first or a second reference value and have been stored in a second memory area of a RAM


266


of the control device


258


of the fifth apparatus


408


. Step SA


411


corresponds to the proper-propagation-velocity determining means


494


.




Step SA


411


is followed by Step SA


412


to determine a coefficient A occurring in the expression (7), based on the proper propagation velocity V


PM1


determined at Step SA


411


and a diastolic BP value DBP


1


determined at Step SA


208


, according to the expression (8). Step SA


412


corresponds to the coefficient determining means


496


. Step SA


412


is followed by Step SA


413


to modify the proper propagation velocity V


PM1


determined at Step SA


411


to a modified, i.e., normalized proper propagation velocity V


M3


corresponding to a predetermined BP value BP


t


and a predetermined pulse rate HR


t


, based on the diastolic BP value DBP


1


and a pulse rate HR


1


measured at Step SA


208


, according to the expression (7). Step SA


413


corresponds to the propagation-velocity modifying means


497


.




Step SA


413


is followed by Steps SA


216


, SA


221


, and SA


222


which are the same as Steps SA


216


, SA


221


, SA


222


of FIG.


11


.




The flow chart of

FIG. 27

represents an interrupt subroutine which is implemented when the CPU


262


reads in the R wave of each heartbeat-synchronous pulse of the ECG waveform (i.e., electric signal) detected by the ECG-waveform detecting device


270


, while the main routine represented by the flow chart of

FIG. 26

is implemented. Step SB


301


of

FIG. 27

is the same as Step SB


301


of FIG.


21


. That is, at Step SB


402


, the CPU


262


of the control device


258


of the fifth apparatus


408


specifies the time when the R wave of one pulse is detected or read in, and stores the specified time in the RAM


266


. Step SB


301


is followed by Step SB


402


to judge whether the CPU


262


has read in one heartbeat-synchronous pulse of the CPW waveform (i.e., CPW signal SM


1


) detected through the pressure sensor


240


. If a negative judgment is made at Step SB


402


, Step SB


402


is repeated until a positive judgment is made. Meanwhile, if a positive judgment is made at Step SB


402


, the control of the CPU


262


goes to Step SB


403


to determine a maximum-slope point K


max


of the pulse of CPW where the differentiated waveform or curve derived from the original CPW waveform shown in

FIG. 25

takes a maximum value, i.e, where the CPW waveform takes a maximum slope. In addition, at Step SB


403


, the CPU


262


determines a maximum-slope line L


Kmax


which passes through the maximum-slope point K


max


and has the maximum slope. Step SB


403


corresponds to the maximum-line determining means


486


.




Step S


403


is followed by Step S


404


to determine a base line BL which passes through the two minimum points before and after the maximum point of the CPW pulse. Step SB


404


corresponds to the base-line determining means


488


. Step SB


404


is followed by Step SB


405


to determine, as the reference point T


S


relating to the CPW pulse, a point of intersection of the maximum-slope line L


Kmax


and the base line BL, as shown in FIG.


25


. Step SB


405


corresponds to the reference-point determining means


490


.




Step SB


405


is followed by Step SB


406


to specify the time when the reference point T


S


of the CPW pulse is detected or read in, and stores the specified time in the RAM


266


. Step SB


406


is followed by Step SB


407


.




At Step SB


407


, the CPU


262


determines a time difference TD


RP


between the time of detection of the R wave of the ECG pulse and the time of occurrence of the reference point T


S


of the corresponding CPW pulse, as illustrated in FIG.


24


. Step SB


407


corresponds to the time-difference determining means


482


. Step SB


407


is followed by Step SB


408


to determine a temporary propagation velocity V


M1


of CPW, based on the time difference TD


RP


determined at Step SB


407


, according to the expression (2). The determined temporary value V


M1


is stored in a first memory area of the RAM


66


. Step SB


408


corresponds to the temporary-propagation-velocity determining means


484


.




Subsequently, at Step SB


409


, the CPU


262


judges whether the amount or rate of change of the current temporary propagation-velocity value V


M1


determined at Step SB


408


in the current control cycle, from the preceding value V


M1


determined at Step SB


408


in the preceding control cycle and stored in the first memory area of the RAM


266


, is not greater than 0.1 m/sec or 3%. If a negative judgment is made at Step SB


409


, the current control cycle in accordance with this subroutine is ended. On the other hand, if a positive judgment is made at Step SB


409


, the control of the CPU


262


goes to Step SB


410


to store temporarily the current propagation-velocity value V


M1


determined at Step SB


408


in the current control cycle, in the second memory area of the RAM


266


. Step SB


409


corresponds to the stability judging means


492


.




As is apparent from the foregoing description, in the fifth embodiment shown in

FIGS. 23

to


27


, the CPU


256


determines, at Step SB


403


, the maximum-slope line L


Kmax


which passes through the maximum-slope point K


max


and has the maximum slope and, at Step S


404


, determines the base line BL which passes through the two minimum points before and after the maximum point of each CPW pulse. In addition, at Step SB


405


, the CPU


262


determines, as the reference point T


S


relating to each CPW pulse, a point of intersection of the maximum-slope line L


Kmax


and the base line BL. This reference point T


S


is free from the influences of a reflected wave as a secondary component of the CPW waveform, as shown in FIG.


25


. Therefore, the reference point T


S


does not substantially change or move on even a CPW waveform obtained from a living subject who suffers a serious arterial sclerosis. Accordingly, the present apparatus


408


measures, with high accuracy, the propagation velocity of a pulse wave which is propagated through an artery of a living subject.




Referring next to

FIGS. 28

to


30


, there will described a sixth embodiment of the present invention which relates to an automatic BP measuring apparatus


508


which automatically measures a BP value of a living subject and which also functions as an apparatus for measuring a propagation velocity of a pulse wave which is propagated through an artery of the subject.




The BP measuring apparatus


508


as the sixth embodiment has the same hardware construction as the BP measuring apparatus


208


as the third embodiment shown in

FIGS. 8 and 9

. The same reference numerals as used in

FIGS. 8 and 9

are used to designate the corresponding elements or parts of the sixth apparatus


508


, and the description thereof is omitted from the following description.




However, as shown in

FIG. 28

, an electronic control device


258


of the sixth apparatus


508


has different control functions


598


,


599


in addition to the same control functions


278


,


280


as those


278


,


280


of the control device


258


of the third apparatus


208


shown in FIG.


10


and the same control functions


482


,


484


,


486


,


492


,


494


,


496


,


497


as those


482


,


484


,


486


,


492


,


494


,


496


,


497


of the control device


258


of the fifth apparatus


408


shown in FIG.


23


.




The sixth apparatus


508


is controlled according to the control program represented by the flow chart of

FIG. 26

employed in the fifth apparatus


408


and the flow chart of FIG.


30


. The subroutine of

FIG. 30

is different from the subroutine of

FIG. 27

employed in the fifth apparatus


408


only in that the former has Steps SC


504


and SC


505


in place of Steps SB


404


and SB


405


of the latter.




The following description relates to only the differences of the sixth apparatus


508


from the fifth apparatus


408


.





FIG. 28

illustrates essential control functions of the control device


258


of the sixth apparatus


508


. The control device


258


functions as a maximum-point-line determining means


598


which determines, with respect to each pulse of the CPW waveform, a maximum-point line, L


Mmax


, (indicated at two-dot chain line in

FIG. 29

) which passes through a maximum point, M


max


, where the waveform of the CPW pulse takes a maximum amplitude, such that the maximum-point line L


Mmax


is parallel to a base line BL which passes through respective minimum points on both sides of the maximum point M


max


of the CPW pulse. In the present embodiment, the amplitude of each point on the CPW waveform is defined as the distance of each point from the base line BL.




The control device


258


of the sixth apparatus


508


also functions as a reference-point determining means


599


which determines a reference point, T


S


, based on a point of intersection, X


2


, of the CPW waveform and a straight line which passes through a point of intersection, X


1


, of the maximum-point line L


Mmax


and a maximum-slope line L


Kmax


(indicated at broken line in

FIG. 29

) determined by a maximum-slope-line determining means


486


and which is perpendicular to the maximum-point line L


Mmax


. More specifically described, a point having an amplitude equal to one fifth of the amplitude of the point X


2


is determined as the reference point T


S


, as shown in FIG.


29


.




Next, there will be described the operation of the BP measuring apparatus


508


constructed as described above. The present apparatus


508


is operated according to the main routine represented by the flow chart of FIG.


26


and the subroutine represented by the flow chart of FIG.


30


. Since, however, the subroutine

FIG. 30

is different from that of

FIG. 27

only in that the former has Steps SC


504


and SC


505


in place of Steps SB


404


and SB


405


of

FIG. 27

, the following description relates only to Steps SC


504


and SC


505


.




At Step SC


504


, the CPU


262


of the control device


258


of the sixth apparatus


508


determines, with respect to each pulse of the CPW waveform, a maximum-point line L


Mmax


which passes through a maximum point M


max


where the waveform of the CPW pulse takes a maximum amplitude, such that the maximum-point line L


Mmax


is parallel to a base line BL which passes through respective minimum points on both sides of the maximum point M


max


of the CPW pulse. Step SC


504


corresponds to the maximum-point-line determining means


598


.




Step SC


504


is followed by Step SC


505


to determine a reference point T


S


based on a point of intersection X


2


of the CPW waveform and a straight line which passes through a point of intersection X


1


of the maximum-point line L


Mmax


and a maximum-slope line L


Kmax


determined at Step SB


403


and which is perpendicular to the maximum-point line L


Mmax


For example, a point having an amplitude equal to one fifth of the amplitude of the point X


2


is determined as the reference point T


S


. Step SC


505


corresponds to the reference-point determining means


599


.




As is apparent from the foregoing description, in the sixth embodiment shown in

FIGS. 28 through 30

, the CPU


262


determines, at Step SB


403


, the maximum-slope line L


Kmax


which passes through the maximum-slope point K


max


Of the CPW waveform and has the maximum slope and, at Step SC


504


, determines the maximum-point line L


Mmax


which passes through the maximum point M


max


of the CPW waveform and extends parallel to the base line BL which passes through the two minimum points on both sides of the maximum point M


max


. In addition, the CPU


262


determines, at Step SC


505


, the reference point T


S


based on the point of intersection X


2


of the CPW waveform and the straight line which passes through the point of intersection X


1


of the maximum-point line L


Mmax


and the maximum-slope line L


Kmax


determined at Step SB


403


and which is perpendicular to the maximum-point line L


Mmax


, for example, determines a point having an amplitude equal to one fifth of the amplitude of the point X


2


, as the reference point T


S


. This reference point T


S


is free from the influences of a reflected wave as a component of the CPW waveform, as shown in FIG.


29


. Therefore, the reference point T


S


does not change or move on even a CPW waveform obtained from a living subject suffering a serious arterial sclerosis. Accordingly, the present apparatus


508


measures, with high accuracy, the propagation velocity of a pulse wave which is propagated through an artery of a living subject.




In the present embodiment, a point having an amplitude equal to one fifth of the amplitude of the point X


2


, is determined as the reference point T


S


. However, it is possible to determine, as the reference point T


S


, a point having an amplitude equal to one third or one tenth of the amplitude of the point X


2


, or otherwise to determine the point X


2


itself as the reference point T


S


.




Referring next to

FIGS. 31 and 32

, there will described a seventh embodiment of the present invention which relates to an automatic BP measuring apparatus


608


which automatically measures a BP value of a living subject and which also functions as an apparatus for measuring a propagation velocity of a pulse wave which is propagated through an artery of the subject.




The BP measuring apparatus


608


as the seventh embodiment has the same hardware construction as the BP measuring apparatus


208


as the third embodiment shown in

FIGS. 8 and 9

. The same reference numerals as used in

FIGS. 8 and 9

are used to designate the corresponding elements or parts of the seventh apparatus


608


, and the description thereof is omitted from the following description.




However, as shown in

FIG. 31

, an electronic control device


258


of the seventh apparatus


608


has a different control function


676


in addition to the same control functions


278


,


280


as those


278


,


280


of the control device


258


of the third apparatus


208


shown in FIG.


10


and the same control functions


482


,


484


,


492


,


494


,


496


,


497


as those


482


,


484


,


492


,


494


,


496


,


497


of the control device


258


of the fifth apparatus


408


as shown in FIG.


23


.




The seventh apparatus


608


is controlled according to the control program represented by the flow chart of

FIG. 26

employed in the fifth apparatus


408


and the flow chart of FIG.


32


. The subroutine of

FIG. 32

is different from the subroutine of

FIG. 27

employed in the fifth apparatus


408


only in that the former has Step SD


603


in place of Steps SB


403


, SB


404


, and SB


405


of the latter.




The following description relates to only the differences of the seventh apparatus


608


from the fifth apparatus


408


.





FIG. 31

illustrates essential control functions of the control device


258


of the seventh apparatus


608


. The control device


258


functions a reference-point determining means


676


which determines, with respect to each pulse of the CPW waveform, a maximum-slope point K


max


(shown in

FIG. 25

) where the CPW waveform takes a maximum slope. For example, the determining means


676


differentiates the CPW waveform and determines, as the maximum-slope point K


max


, a point where the differentiated waveform or curve takes a maximum value. In addition, the determining means


676


determines the maximum-slope point K


max


as a reference point, T


S


.




Next, there will be described the operation of the BP measuring apparatus


608


constructed as described above. The present apparatus


608


is operated according to the main routine represented by the flow chart of FIG.


26


and the subroutine represented by the flow chart of FIG.


32


. Since, however, the subroutine

FIG. 32

is different from that of

FIG. 27

only in that the former has Step SD


603


in place of Steps SB


403


, SB


404


, and SB


405


of

FIG. 27

, the following description relates only to Step SD


603


.




At Step SD


603


, a CPU


262


of the control device


258


of the seventh apparatus


608


determines, with respect to each pulse of the CPW waveform, a maximum-slope point K


max


of the CPW pulse where the differentiated waveform or curve derived from the original CPW waveform shown in

FIG. 25

takes a maximum value, i.e, where the CPW waveform takes a maximum slope. In addition, the CPU


262


determines the maximum-slope point K


max


as the reference point T


S


. The time of occurrence of this reference point T


S


is specified at Step SB


406


, and this time is used to determine a time difference TD


RP


at Step SB


407


. Step SD


603


corresponds to the reference-point determining means


676


.




As is apparent from the foregoing description, in the seventh embodiment shown in

FIGS. 31 and 32

, the CPU


262


determines, at Step SD


603


, the maximum-slope point K


max


of each pulse of the CPW waveform and determines this point K


max


as the reference point T


S


. The reference point T


S


is free from the influences of a reflected wave as a component of the CPW waveform, as shown in FIG.


25


. Therefore, the reference point T


S


does not change or move on even a CPW waveform obtained from a living subject having a serious arterial sclerosis. Accordingly, the present apparatus


608


measures, with high accuracy, the propagation velocity of a pulse wave which is propagated through an artery of a living subject.




While in each of the fifth to seventh embodiments the propagation velocity V


M1


, V


PM1


, V


M3


is determined based on the time difference TD


RP


between each pulse of the ECG waveform and a corresponding pulse of the PPW or CPW waveform, it is possible to determine a propagation velocity based on a time difference of a heartbeat-synchronous pulse of a first pulse wave detected by a first pulse-wave sensor and a corresponding heartbeat-synchronous pulse of a second pulse wave detected by a second pulse-wave sensor. In the latter case, the two pulse-wave sensors are worn on different portions of the subject, and a reference point T


S


is determined with respect to each of the first and second pulse waves. The two pulse-wave sensors correspond to the pair of heartbeat-synchronous-wave sensors, and the two pulse waves correspond to the two heartbeat-synchronous waves, respectively.




It is to be understood that the present invention may be embodied with various changes, improvements, and modifications that may occur to those skilled in the art without departing from the scope and spirit of the invention defined in the appended claims.



Claims
  • 1. An apparatus for measuring a propagation velocity of a pulse wave which is propagated through an artery of a living subject, the apparatus comprising:a blood-pressure measuring device which includes an inflatable cuff adapted to be wound around a body portion of the subject, a pulse-wave sensor which detects the pulse wave transmitted from the artery of the subject to said cuff when a pressure in the cuff is changed, and means for determining a blood pressure value of the subject based on the detected pulse wave; an electrocardiographic-waveform detecting device which includes a plurality of electrodes adapted to contact a body surface of the subject and which detects an electrocardiographic waveform from the subject through said electrodes; time-difference determining means for successively determining a time difference between a first periodic point relating to the detected electrocardiographic waveform and a second periodic point relating to the detected pulse wave; temporary-propagation-velocity determining means for successively determining a temporary propagation velocity of the pulse wave based on each of the successively determined time-difference values; judging means for judging whether the change of each of the successively determined temporary propagation-velocity values with respect to the change of said cuff pressure is smaller than a reference value; and proper-propagation-velocity determining means for determining a proper propagation velocity from at least one temporary propagation-velocity value for which a positive judgment is made by said judging means.
  • 2. An apparatus according to claim 1, wherein said proper-propagation-velocity determining means comprises means for determining, as said proper propagation velocity, an average of a plurality of temporary propagation-velocity values for each of which said positive judgment is made by said judging means.
  • 3. An apparatus according to claim 1, further comprising proper-propagation-velocity modifying means for modifying the determined proper propagation-velocity value to a modified proper propagation-velocity value corresponding to a predetermined blood pressure value, based on the measured blood pressure value, according to a predetermined relationship between modified proper propagation velocity, and determined proper propagation velocity and measured blood pressure.
  • 4. An apparatus according to claim 3, further comprising means for determining a degree of arterial sclerosis of the subject based on said modified proper propagation-velocity value according to a predetermined relationship between degree of arterial sclerosis and modified proper propagation velocity.
  • 5. An apparatus for measuring a propagation velocity of a pulse wave which is propagated through an artery of a living subject, the apparatus comprising:a blood-pressure measuring device which includes an inflatable cuff adapted to be wound around a body portion of the subject, a pulse-wave sensor which detects a plurality of heartbeat-synchronous pulses of the pulse wave transmitted from the artery of the subject to said cuff when a pressure in the cuff is changed, and means for determining a blood pressure value of the subject based on variation of respective amplitudes of the detected heartbeat-synchronous pulses of the pulse wave; an electrocardiographic-waveform detecting device which includes a plurality of electrodes adapted to contact a body surface of the subject and which detects an electrocardiographic waveform from the subject through said electrodes; time-difference determining means for successively determining a time difference between a first periodic point relating to each of heartbeat-synchronous pulses of the detected electrocardiographic waveform and a second periodic point relating to a corresponding one of the detected heartbeat-synchronous pulses of pulse wave; propagation-velocity determining means for successively determining a propagation velocity of the pulse wave based on each of the successively determined time-difference values; judging means for judging whether the change of each of the successively determined propagation-velocity values with respect to the change of the cuff pressure is smaller than a reference value; and correcting means for correcting at least one first pulse of the heartbeat-synchronous pulses of the pulse wave which is deviated from at least one second pulse for which a positive judgment is made by said judging means, based on the deviation of the first pulse from the second pulse, so that said blood-pressure measuring device measures the blood pressure value of the subject based on the variation of the respective amplitudes of the heartbeat-synchronous pulses including the corrected first pulse.
  • 6. An apparatus according to claim 5, wherein said correcting means comprises:estimating means for estimating, based on a plurality of the determined propagation-velocity values for each of which said positive judgment is made by said judging means, a next propagation-velocity value which will be determined by said propagation-velocity determining means; and difference determining means for determining a difference between the estimated next propagation-velocity value and an actual next propagation-velocity actually determined by said propagation-velocity determining means.
  • 7. An apparatus according to claim 6, wherein said correcting means further comprises means for determining a correction value based on the determined difference according to a predetermined expression, and adding said correction value to an amplitude of said first pulse.
  • 8. An apparatus according to claim 6, wherein said correcting means further comprises means for determining a correction value based on the determined difference according to a predetermined expression, and adding said correction value to a value of said cuff pressure at a time of detection of said first pulse.
  • 9. An apparatus for measuring a propagation velocity of a pulse wave which is propagated through an artery of a living subject, the apparatus comprising:a blood-pressure measuring device which includes an inflatable cuff adapted to be wound around a body portion of the subject, a pulse-wave sensor which detects the pulse wave transmitted from the artery of the subject to said cuff when a pressure in the cuff is changed, and means for determining a blood pressure value of the subject based on the detected pulse wave; an electrocardiographic-waveform detecting device which includes a plurality of electrodes adapted to contact a body surface of the subject and which detects an electrocardiographic waveform from the subject through said electrodes; time-difference determining means for determining a time difference between a first periodic point relating to the detected electrocardiographic waveform and a second periodic point on relating to the detected pulse wave; propagation-velocity determining means for determining a propagation velocity of the pulse wave based on the determined time-difference value; and terminating means for terminating a blood pressure measurement of said blood-pressure measuring device when the determined propagation-velocity value does not fall within a permission range.
  • 10. An apparatus according to claim 9, further comprising a memory which stores data indicative of a plurality of said permission ranges corresponding to a plurality of values of said cuff pressure at which a plurality of propagation-velocity values are determined by said propagation-velocity determining means.
Priority Claims (4)
Number Date Country Kind
7-307353 Nov 1995 JP
7-307354 Nov 1995 JP
8-010619 Jan 1996 JP
7-287339 Nov 1999 JP
Parent Case Info

This is a Division of application Ser. No. 09/157,215 filed Feb. 4, 1998, now U.S. Pat. No. 6,120,480, which in turn is a Divisional of application Ser. No. 08/718,715 filed Sep. 24, 1996, now U.S. Pat. No. 5,783,856. The entire disclosure of the prior application is hereby incorporated by reference herein in its entirety.

US Referenced Citations (10)
Number Name Date Kind
5099852 Meister et al. Mar 1992 A
5237997 Greubel et al. Aug 1993 A
5241964 McQuilkin Sep 1993 A
5279303 Kawamura et al. Jan 1994 A
5309916 Hatschek May 1994 A
5564427 Aso et al. Oct 1996 A
5603329 Hosaka et al. Feb 1997 A
5649543 Hosaka et al. Jul 1997 A
5755669 Ono et al. May 1998 A
5876348 Sugo et al. Mar 1999 A
Foreign Referenced Citations (2)
Number Date Country
0 498 281 Aug 1992 EP
A-60-220037 Jan 1985 JP
Non-Patent Literature Citations (1)
Entry
J. Weinman and D. Sapoznikov, “Equipment for Continuous Measurements of Pulse Wave Velocities,” Medical Biological Engineering: Journal of the International Federation for Medical and Biological Engineering, Mar. 1971, vol. 9, pp. 125-138.